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The principal aim of this research was to explore whether individuals with temporal
lobe epilepsy and significant memory dysfunction experienced lower quality of life.
Executive functioning and locus of control issues in temporal lobe epilepsy were also
explored.
Methodology
A within subject design was used to explore these issues. Twenty two participants
with temporal lobe epilepsy underwent a neuropsychological assessment and
completed 3 questionnaires: the Quality of Life in Epilepsy - 31 item questionnaire,
the Multidimensional Health locus of control Scale and the Hospital Anxiety and
Depression Scale. Pearson correlations were used to investigate relationships
between variables.
Results
A significant positive relationship between memory functioning and quality of life
was revealed. Executive functioning was also shown to be an important factor
influencing quality of life and memory in temporal lobe epilepsy. The influence of
locus of control on memory and quality of life was less than anticipated.
Conclusions
The results were discussed in relation to current literature and their implications in







Epilepsy has a considerable historical past. In ancient times, it was known as the
"Sacred Disease" with many believing it a gift and others a curse from the gods.
Throughout history, individuals with epilepsy have been stigmatised, shunned, and
even imprisoned. In some countries, such as Tanzania, epilepsy continues to be
associated with possession by evil spirits and/or witchcraft, and is believed by many
to be contagious (Jilek-Aall, 2006). The Greek philosopher Hippocrates (460-377
BC) was the first to suggest that epilepsy originates from the brain rather than from
some kind of divine higher power:
"It is thus with regard to the disease called sacred: it appears to me to be in no way
more divine nor more sacred than other diseases...
The brain is the cause of this affliction. " (Hippocrates, 460-377 BC)
A possible link between epilepsy and greatness has fascinated biographers and
physicians for centuries. Many figures from history, including Hercules, Van Gogh,
Lewis Carol and Napoleon have been thought to have epilepsy. Saints and other
religious figures have also been linked to the condition (Dewhurst & Beard, 2003).
Peter Fenwick (1994) has questioned the widespread labelling of famous figures with
epilepsy and believes this may "owe more to the enthusiasm of their authors than to
the true scientific understanding" (pp.1). In a more recent detailed review of the
subject, neurologist John Hughes (2005) concluded that the majority of famous
people alleged to have epilepsy, probably did not have the condition.
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1.1.2 What is Epilepsy?
The words "epilepsy" and "epileptic" are of Greek origin and have the same origin as
the verb "epilambanein," meaning "to seize" or "to attack". Epilepsy is one of the
most commonly known neurological conditions. It is a "chronic disorder
characterised by recurrent seizures" (Gestaut, 1973) and "reflects an episodic
disturbance of behaviour or perception arising from hyper excitability and hyper
synchronous discharge of nerve cells in the brain that can be associated with a
variety of aetiologies" (Lezak et al, 2004). Van Rijckevorsel (2006) stresses the
point that epilepsy should not be considered a disease but rather as a symptom
indicating, rather than causing, brain dysfunction.
1.1.3 Prevalence
Up to 5% of the world's population may have a single seizure at some time in their
lives (often as a result of high temperature or severe dehydration), but a diagnosis of
epilepsy is reserved for those who have recurring seizures or at least two unprovoked
ones. The World Health Organisation estimates that approximately 50 million
people in the world have epilepsy at any given time (WHO, 2001). The prevalence
figures are generally higher in developing countries compared with developed
countries. The reason for this is unclear, although social deprivation has been put
forward as an explanation (Sander & Shorvon, 1996). Interestingly, recent data
suggests that people from socio-economically deprived backgrounds in developed
countries are also more prone to developing epilepsy (Sander, 2003).
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The National Epilepsy Society (2006) indicates that one in every 130 people in the
UK have epilepsy, meaning that there are currently approximately 450,000 people
with epilepsy in the UK. In Scotland, it is estimated that there are 20,000-40,000
people with active epilepsy and between 2,000 and 3,500 newly diagnosed cases
each year (SIGN, 2003). Epilepsy can affect anyone at any age, and males appear
more prone to developing it than females (Cull & Goldstein, 1997).
1.1.4 Economic Cost
The Clinical Guidelines for the Management of Epilepsy, published in 2004 by the
National Institute for Health and Clinical Excellence (NICE), reported that the
medical cost of treating people with epilepsy in England alone was over £23 million,
rising to almost £28 million across the UK. The non-medical costs (for example,
social services and care costs) are reported to be significantly higher at more than
£111 million in England and over £132 million across the whole of the UK, bringing
the combined costs across the UK to over £160 million. These figures emphasise the
importance of exploring non-medical issues as well as medical ones in epilepsy.
1.1.5 Aetiology
Epilepsy is characterised as being idiopathic, cryptogenic or symptomatic.
Idiopathic epilepsies have no known aetiology and are not usually associated with
other neurological disorders, and consequently, neuropsychological deficits are
generally absent (Perrine et al, 1991). The aetiology of cryptogenic epilepsy is also
unknown, but patients' neurological and neuropsychological profiles are usually
atypical. It is generally accepted that 60-70% of all epilepsies have no clear cause
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and their aetiology remains a key issue for researchers (Sander, 2005). Seizures with
known aetiology are referred to as symptomatic. Where causes can be identified,
they may be varied in nature (Cull & Goldstein, 1997). A number of individuals
have attempted to review and categorise the causes of epilepsy (Lishman, 1997;
Sander et al 1990). Figure 1 illustrates the main causes revealed in a community-
based study of epilepsy in the United Kingdom (the National General Practice Study
of Epilepsy) (Sander et al 1990):
b% 2%
Figure 1: Causes of epilepsy as found in Sander et al (1990) study
Other causes of epilepsy are rare but may include birth injury or congenital
malformations, infections, and neurodegenerative disorders.
1.1.6. Seizure Classification
Seizure types are categorised according to whether they are localised (partial or focal
onset seizures) or distributed across the cortex (generalised seizures). Brain scans
and electroencephalographic (EEG) often provide useful information for those trying
to diagnose and differentiate between the various seizure types (Fowler, 2000; King
1998). However many seizures are difficult to classify. Chadwick (2005) highlights
that seizure classification can be biased, and is usually most accurate in patients with
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frequently occurring severe epilepsy, where there is a greater likelihood of observing
an EEG correlate of the seizure. Tables 1 and 2 summarise the classification of
seizures as presented by the International League Against Epilepsy (1981). Although
several revisions have been suggested this classification is still the most commonly
used:
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Tables 1 & 2: International Classification of Seizures
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1.1.6 (a) Partial or Focal seizures
Approximately two thirds of the epilepsy population experience partial seizures
(Martin et al, 2006). These begin locally in the cortex and are often preceded by an
aura (a psychic or sensory disturbance that warns individuals that they are about to
have a seizure). Partial seizures are further divided into partial and complex seizures
depending on the extent to which consciousness is affected. If consciousness is
unaffected, then it is termed a simple partial seizure. The most common sites of
origin for simple partial seizures are within the frontal or temporal lobes (Chadwick,
2005).
Complex partial seizures are differentiated from simple partial seizures by varying
degrees of consciousness. The individual loses awareness during a complex partial
seizure because the seizure spreads to involve both temporal lobes. This impairment
in consciousness may be preceded by symptoms of a simple partial seizure, usually
by those associated with the temporal lobe region. However, in some circumstances
consciousness may be lost from the outset. Such seizures are often associated with
repetitive stereotyped behaviours or ictal automatisms (for example, fidgeting, lip
smacking or chewing and clothes picking). Sometimes, more complex behaviour is
exhibited, which in extreme circumstances can lead to inappropriate behaviours such
as indecent exposure or shoplifting. Forced repetitive thoughts, changes in mood,
hallucinations and/or feelings of deja vu are sometimes experienced, as are postural
changes. Complex partial seizures are frequently followed by post-ictal activity (for
example, confusion, reduced attention and/or impaired coordination) (Chadwick,
2005). Both simple and complex partial seizures may spread more generally to
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involve both hemispheres and result in a tonic-clonic seizure (secondary generalised
seizure).
1.1.6 (b) Generalised seizures
Approximately one third of all patients with epilepsy suffer from generalised seizures
(Martin et al, 2006). Generalised seizures commence bilaterally (that is both
hemispheres are affected) and consciousness is usually lost suddenly, so that the
patient experiences no aura. They are categorised according to the effect they have
on the body, and they all involve loss of consciousness. They include absence (petit
mal), myoclonic, clonic, tonic, tonic-clonic (grand mal), and atonic seizures.
Typical absences (previously called petit mal) are characterised by a sudden,
cessation of ongoing activity when the individual loses contact with their
environment and stops activity. There may be some minor myoclonic activity
around the eyelids. These attacks may last up to 30 seconds and come to a sudden
end with no post-ictal confusion (Chadwick, 2005).
Atypical absences usually occur in symptomatic epilepsy in individuals with pre¬
existing brain damage. They are more prolonged and are often associated with
myoclonic activity or atonic attacks, which may result in the individual being thrown
to the ground, frequently suffering trauma (Chadwick, 2005).
Myoclonic seizures occur as single and/or multiple jerking movements, which may
be generalised to the face, trunk, or one or more limbs or muscle groups. These
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contractions are especially common on falling asleep or waking, and occur as part of
idiopathic generalised epilepsy or as part of a mixed seizure disorder such as
Lennox-Gestaut syndrome. They are also seen in Creutzfeldt-Jakob disease (Cull &
Goldstein, 1997).
Tonic-clonic seizures (previously called grand mal) are the most common form of
generalised seizure. They may occur in a primary fashion or following
generalisation after a partial seizure. When they are of primary origin, the patient
does not experience any aura but may describe a more non-specific and longer
lasting prodrome of general malaise (Chadwick, 2005). Tonic seizures may occur
without the clonic component, and similarly clonic seizures may occur on their own.
In the tonic stage muscles become rigid and fixed and in the clonic stage muscles
alternately contract and relax.
Atonic seizures are characterised by a decrease in muscle tone and the person falling
to the ground. These are often referred to as drop attacks and need to be
distinguished from similar attacks that occur in narcolepsy/cataplexy (Cull &
Goldstein, 1997).
There are many different epilepsy syndromes, each presenting with its own unique
combination of seizure type, typical age of onset, EEG findings, treatment, and
prognosis. These include frontal lobe, temporal lobe, juvenile myoclonic, occipital
lobe, Lennox-Gestaut Syndrome, childhood absence epilepsy and infantile syndrome
(West Syndrome). There is a tendency for researchers in this area to use the term
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'epilepsy' without specifying type and this can make interpretation of data difficult.
In this study, the focus will be on temporal lobe epilepsy.
1.2 TEMPORAL LOBE EPILEPSY
Temporal lobe epilepsy was first recognised by Hughling Jackson in 1881. The
International League Against Epilepsy (1981) defines temporal lobe epilepsy as a
condition characterised by recurrent unprovoked seizures originating from the medial
or lateral temporal lobe. Temporal lobe epilepsy can manifest itself as simple or
complex partial seizures. It is the most common type of seizure disorder, occurring
in approximately 40-60% of patients with epilepsy. Patients with temporal lobe
epilepsy often present with the following: febrile seizures; early onset in childhood;
early anoxic episodes in childhood; family history of epilepsy; resistance to
antiepileptic medication and mesial temporal sclerosis on neuroimaging, (although
more widespread abnormalities can be present) (Berg et al, 1996). Mesial temporal
sclerosis involves neuronal loss and gliosis (scarring) within the mesial temporal
structures.
Diagnosing epilepsy if often difficult and misdiagnosis is common (Beghi, 2007).
Diagnosing temporal lobe epilepsy is challenging because it is difficult to be accurate
about exactly where seizures originate from in the brain. Classically the expression
more often refers to mesial temporal epilepsies rather than lateral temporal
epilepsies. Without in depth electrode studies and/or a clear-cut abnormality on scan
with supporting evidence from surface EEG that the structural abnormality seen is
also the site of seizure onset it is impossible to state this diagnosis with absolute
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certainty. Many have an aura suggestive of mesial temporal onset and are therefore
viewed as having "probable temporal lobe epilepsy". In reality, many neurologists
often avoid using the term stating instead what type of seizure a patient experiences
for example, "complex partial seizures with or without secondary generalisation" and
where relevant giving a description of the individual's aura.
1.3. PSYCHOLOGICAL ISSUES
It is becoming increasingly recognised that epilepsy has profound social and
psychological consequences (Au et al, 2002; Thomson & O'Toole, 2005). Arguably,
the impact of these psychosocial difficulties is more significant than the physical
symptoms of the condition (Baker et al, 2000; MacLeod & Austin, 2003). A number
of factors leading to the neuropsychiatric features of epilepsy have been suggested.
These include the possibility that epileptiform discharges originating from the central
nervous system provoke emotional responses; the functional limitations associated
with seizures; perceived social stigma; and/or the possible adverse effect of
antiepileptic drugs (Bortz 2003).
Up to 50-60% of patients with chronic epilepsy have mood disorders, with anxiety
and depression being particularly prevalent (Beyenburg et al, 2005). The general
rate of mood disorder in epilepsy patients has been shown to be higher than both the
general population and patients with other chronic medical conditions such as
diabetes and asthma (Blum et al, 2002; Bortz, 2003; Moore & Baker, 2002). In
addition, people with epilepsy are more likely to be unemployed or underemployed,
have lower rates of marriage and experience greater social isolation (Jacoby et al,
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1996; Moore & Baker, 2002). In the UK, many still feel that revealing their
condition will deter their employers who may view them as unreliable and likely to
cause accidents (Usiskin, 2005). Research indicates that individuals with epilepsy
are up to twice as likely to be unemployed and are frequently subject to
underemployment, relative to their skills and qualifications. This has consequences
for their financial status and psychological well-being (Baker, 2005).
A number of studies have reported an increased rate of psychiatric disturbance in
patients with temporal lobe epilepsy, compared with patients with other types of
epilepsy (Perini et al, 1996; Quiske et al, 2000). However, other researchers have
failed to document an association between temporal lobe epilepsy and psychiatric
symptoms (Fedderson et al, 2005; Issacs et al, 2004; Swinkels et al, 2001).
1.3.1 Depression
Hippocrates was the first to suggest a bi-directional relationship between epilepsy
and depression. He wrote that "melancholies ordinarily become epileptics, and
epileptics melancholies" (Lewis, 1934). Recent studies have explored the possibility
that the two disorders have a bi-directional relationship: that is, not only are patients
with epilepsy at greater risk of developing depression, but patients with depression
have a greater risk of developing epilepsy (Frucht et al, 2000; Hesdorffer et al, 2000;
Schmid-Schonbein, 1998; Taher et al, 2005). It has been proposed that this
relationship may be due to disturbances in the central nervous system's serotonergic
activity (Hesdorffer et al, 2006).
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A review by Kanner (2003) indicated that the prevalence of depression ranges from
20-55% in patients with ongoing seizures and from 3%-9% of patients with well-
controlled seizures. Another review summarised published prevalence rates of major
depression in-patients with chronic epilepsy. They reported estimates ranging from
8-48% and both mean and median rates of approximately 30% (Bortz, 2003).
Several studies indicate that depression is more frequently reported in temporal lobe
epilepsy and left-sided foci, although not all studies support this finding (Harden,
2002). Suicide has also been reported to be 4-5 times more common in epilepsy, as
has hospitalisation, especially in temporal lobe epilepsy where seizures arc
frequently uncontrolled (Grabowska-Grzyll et al, 2006).
1.3.2 Anxiety
Much attention has focused on depression, although a systematic review conducted
by Beyenburg et al (2005) indicated that anxiety "may actually be more common and
equally disabling" (Goldstein & Harden, 2000; Marsh & Rao, 2002; Vazquez &
Devinksy, 2003). This review points to evidence as far back as 1971, when Currie et
al (1971) recorded a 19% prevalence of anxiety disorder, compared with an 11%
prevalence of depressive disorder, in patients with temporal lobe epilepsy. Vazquez
and Devinsky (2003) summarised the prevalence of anxiety in epilepsy as ranging
between 15-25%, when using well-defined diagnostic criteria for anxiety disorders.
1.3.3. Personality disorder
An increased prevalence of personality traits or disorders is frequently found in
epilepsy patients, with estimates of co-morbidity somewhere between 29-50%
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(Lishman, 1997; Swinkels et al, 2003, 2006; Schwartz & Cummings, 1988).
Individuals with epilepsy appear to be at an increased risk of developing psychotic
conditions compared with the general population, particularly schizophrenia-like and
paranoid states (Aldencamp & Hendriks, 2000).
1.3.4 Factors Influencing Psychosocial Issues
Research has identified a number of factors that may predict psychosocial adjustment
in epilepsy. These include clinical (age at onset, seizure type, seizure frequency, and
severity), demographic (age, sex, employment and marital status) and
neuropsychological factors (memory, executive functioning) (Baker et al, 1996,
Jacoby et al, 1996).
Many negative connotations are attached to epilepsy. Seizures do not conform to
society's expectations of predictability and self-control in everyday behaviour
(Shafer, 2002). As a result, people with epilepsy are often prevented from
participating in activities, which can jeopardise both their emotional wellbeing and
development of social relationships. In addition, seizures themselves (especially if
they are uncontrolled) can restrict an individual's activity and therefore their level of
social contact for example, seizures may prevent a person from driving.
Uncertainty and a lack of control constitute a common theme in the experience of
patients with epilepsy and should be considered a significant aetiological factor in
the development of psychosocial problems in epilepsy (Au et al, 2002). Baker
(2001) highlights the unpredictable nature and course of epilepsy. This can cause
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patients with epilepsy to feel that they have a lack of control over seizure activity and
these feelings can often become generalised to other aspects of their lives (Au et al,
2002; Gehlert, 1994). Over time, patients may begin to believe that their health is
significantly more a matter of chance than of their own doing.
It is importance to stress the negative impact that these psychological difficulties can
have on an individual's everyday functioning and quality of life (Janukainen, 1995).
One of the key challenges to those working in the epilepsy field is how to influence
the impact of these factors and in so doing ameliorate the deleterious impact they can
have.
1.4 LOCUS OF CONTROL
The concept of locus of control was originally developed in the 1950s (Rotter, 1954).
Locus of control refers to an individual's perception about the underlying main
causes of events in his/her life. The concept is often divided into two categories
namely external and internal locus of control. People with a strong internal locus of
control believe that success or failure is due to their own efforts whereas externals
believe that events are controlled by luck, chance, or powerful others. Those
classified as having higher external locus of control consider their own efforts as
having relatively little effect on the amount of reinforcement they receive. There is
research to suggest that such individuals are more likely to be stressed and suffer
from depression, as they are more aware of work situations and life strains (Benassi,
Sweeney & Dafour, 1988; Hogg & Vaughan, 1995).
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An alternative model to Rotter's has been put forward (Levenson, 1973). Rather
than view locus of control as one-dimensional (internal to external), it suggests that
there were three independent dimensions: internality, chance, and powerful others.
According to this model, an individual can hold each of these dimensions of locus of
control independently and/or at the same time. For example, an individual might
simultaneously believe that both oneself and powerful others influence outcomes but
that chance does not.
Since its introduction, the locus of control construct has undergone considerable
elaboration and several context-specific instruments have been developed. Health
researchers in particular have embraced locus of control as a concept for explaining
behavior. Among the most widely used health-specific measures is the
Multidimensional Health Locus of Control Scales (Wallston et al, 1978). This
instrument retains Levenson's three dimensions but concerns outcomes that are
specifically related to health and illness, such as staying well or becoming ill.
The Multidimensional Health Locus of Control scales have met criticism on a more
general basis, and the utility of the concept of locus of control is often questioned
(Wallston, 1992). However, many support its use and argue that perceived control is
a promising construct despite these widely recognised theoretical and methodological
limitations (Norman et al, 1995; Wallston, 2001).
Epilepsy is a disorder characterised by loss of control (Matthews et al, 1982). For
many people with the condition, seizures may occur at any time with little warning.
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The constant threat of a sudden, unpredictable loss of control has been thought to be
a central aspect of the condition (Baker, 2001). Repeated exposure to uncontrollable
and unpredictable adverse events such as seizures has been hypothesised to diminish
a person's sense of control over both environmental and internal factors, resulting in
a pervasive sense of "learned helplessness" (Seligman et al, 1975). This may lead to
an attributional style where patients come to believe that they have little internal
control over events and/or their symptoms and they attribute their lack of control and
other negative events or symptoms to external causes (chance and the actions of
others). Compared with other chronic conditions, research has indicated that
epilepsy is associated with a significantly greater external locus of control (Matthews
& Barabas, 1981).
1.5 COGNITIVE FUNCTIONING
Cognition can be defined as the capacity of the brain to process information
accurately and to program adaptive behaviour (Van Rijckevorsel, 2006). Cognition
fulfils an essential role in our lives and personality and can be potentially affected by
a variety of central nervous system processes especially those which are chronic such
as epilepsy (Trimble et al 1994). Overall, individuals with epilepsy tend to report
and demonstrate cognitive dysfunction compared to age matched controls in the
general population (Smith et al, 1996; Trimble et al, 1996). A number of authors
highlight that cognitive profiles in different epilepsies demonstrate great diversity
and are probably as heterogeneous as the epileptic syndromes themselves (Elger et
al, 2004; Gupta & Naorem, 2003; Mameniskiene, 2006). However, common
complaints include memory problems, decreased levels of attention and
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concentration, slowness in thinking and lack of motivation (Bennett, 1992).
Cognitive dysfunction in patients with epilepsy can be a major contributor to the
burden of the disease and can significantly disrupt many aspects of a person's life.
Early onset may result in more generalised cognitive dysfunction, as the maturing
brain is affected and organisational processes encumbered. Later onset is often
associated with greater partial impairment especially in memory (Helmstaedter &
Gates, 2006). In addition, there is evidence to suggest that cognitive problems may
actually antedate a diagnosis of epilepsy. Although research is limited in this area
and the mechanisms which might explain this effect remain unclear (Hermann &
Seidenberg, 2007).
Cognition appears to be affected by multiple factors including seizure aetiology,
seizure control, seizure frequency and duration, seizure severity, hereditary factors,
psychosocial conditions and anti epileptic drug effects (Lennox, 1942; Lesser et al,
1986; Loring & Meador, 2001; Meador, 2001).
A large body of evidence now exists detailing the neuropsychological deficits that
often accompany temporal lobe epilepsy (Exner et al, 2002). Interestingly, the
duration of the disorder in years appears to be positively correlated with the degree
of neurocognitive dysfunction (Strauss et al, 1995). Recent examinations of the
neurodevelopmental impact of childhood onset temporal lobe epilepsy supports the
presence of widespread neurocognitive dysfunction as well as diffuse brain structure
abnormalities (Hermann et al, 2002).
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1.5.1 Executive Functioning
Executive functioning relates to a person's capacity to engage successfully in
independent, purposive, self-serving behaviour (Lezak et al, 2004). Exploration of
neuropsychological deficits in temporal lobe epilepsy has tended to focus on memory
problems however, it is becoming increasingly recognised that difficulties in
executive functioning often arise (Hermann & Seidenberg, 1995). Studies
correlating neuropsychological testing and functional brain imaging support this
view by confirming executive dysfunction in temporal lobe epilepsy patients
(Herman et al, 1988; Jokeit et al, 1997).
Studies have revealed that patients with temporal lobe epilepsy experience difficulty
with the Wisconsin Card Sorting Test (WCST) (Martin et al, 2006). This is a well-
known test of executive functioning that particularly focuses on set-shifting ability.
Traditionally, patients with any sort of frontal lobe lesion are said to generally
perform poorly on this test. Interestingly, Hermann et al (1988) reported that 74% of
non-dominant temporal lobe epilepsy patients and 39% of patients with dominant
temporal lobe epilepsy foci performed on the WCST in a manner that would
normally be considered 'frontal'. Horner et al (1996) also reported a high number of
perseverative errors by temporal lobe epilepsy patients on the WCST (irrespective of
lateralisation of focus). Several factors may affect WCST performance in temporal
lobe epilepsy patients including side of focus, age of onset of epilepsy (Strauss et al,
1993) and mood (Seidenberg et al, 1995).
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Another study comparing executive functioning in frontal and temporal lobe epilepsy
patients indicated that in temporal lobe epilepsy, seizure frequency was primarily
responsible for errors displayed in the inhibition/switching condition (McDonald et
al, 2005). This study indicated that no other demographic, disease-related, or
psychological factors contributed to the participants' performance. This finding is
supported by other research indicating that higher seizure frequency is associated
with greater cognitive dysfunction in temporal lobe epilepsy, possibly through
secondary neuronal metabolic and/or structural deterioration (Dodrill, 1986).
Frequent seizure activity in patients with temporal lobe epilepsy may be associated
with the development of white matter abnormalities or metabolic changes in the
frontal lobes that are undetected on standard imaging, but which nevertheless
contribute to executive dysfunction (Hermann et al, 2003).
A number of hypotheses regarding executive dysfunction in temporal lobe epilepsy
have been identified (Bougakov, 2005). The nociferous hypothesis states that the
epileptogenic cortex adversely affects the extratemporal regions that mediate
executive system abilities, thereby resulting in performance deficits. Related to this
is the possibility that executive dysfunction may be explained by the connections
between the temporal and frontal regions. In addition, temporal lobe seizures may
spread via the frontal regions, resulting in dysfunction from both regions.
Alternatively, the hippocampal hypothesis suggests that such impairments are due to
direct hippocampal involvement in the mediation of executive function and that
performance deficits are directly attributable to hippocampal pathology. Bougakov's
(2005) study supported the view that individuals with temporal lobe epilepsy have
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executive dysfunction but did not provide a satisfactory explanation about the
mechanisms underlying this.
In summary, subsets of patients with temporal lobe epilepsy, particularly those with
left medial temporal sclerosis, do appear to exhibit executive dysfunction especially
on demanding, multilevel executive tasks. The nature and origin of these difficulties
requires further explanation. The degree of this executive dysfunction in temporal
lobe epilepsy patients may depend on seizure frequency or related factors (for
example, prefrontal white matter damage secondary to frequent seizure propagation)
(McDonald et al, 2005).
1.5.2. Attention
Attention is the is the cognitive process involved in perceiving, selecting and
maintaining or detaching focus from stimuli. Impairments in attention are among the
most common manisfestations of brain damage and the impairment of sustained
attention is consistently described in epilepsy (Van Rijckevorsel, 2006). It is
difficult to consider attentional processes without reference to working memory.
This refers to the capacity of to hold and manipulate information for a short period of
time. Research suggests that working memory is not commonly not affected by
medial temporal region damage in adult humans and animals. However, long-term
memory, the ability to store information for later recall, is impaired following
damage to or disruption of components of the medial temporal region. In general,
delays greater than 15-30 seconds on these tasks are sensitive to medial temporal
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damage (Hershey et al, 1998). However, this may differ across specific task
demands, materials and the nature of the lesion.
1.5.3 Memory Functioning
Memory refers to the ability to store, retain, and subsequently recall information. It
is not a single system but rather there are many different types including working,
long term, remote, prospective and procedural memory. Memory dysfunction is the
most frequently reported cognitive problem in epilepsy (Hendriks et al, 2002;
Hermann et al, 1996; Leritz, 2006). The prevalence of memory problems in patients
with refractory epilepsy has been estimated to be between 20-50% (Halgren et al,
1991). Ponds and Hendrik (2006) analysed subjective memory complaints in a
sample of 252 epilepsy patients with intractable seizures, using a standardised
memory questionnaire for patients with epilepsy. Participants particularly
complained about memory problems that reflected 'absent minded behaviour', such
as mislaying items. In other words, they struggled with the retrieval of complex
meaningful episodic information. These results appear to be comparable with other
studies (Helmstaedter, 2001; Thomson & Corcoran, 1992).
Epilepsy carries a high risk of memory dysfunction on both organic and behavioural
grounds. Underlying brain pathology is probably the most influential cause of
memory disturbance in epilepsy. Although, evidence indicates that several other
factors may also cause or exacerbate memory problems including type of epilepsy,
age at onset and duration, seizure activity, anti-epileptic drugs, surgery and mood
(Thomson, 1997).
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Decades of research have provided substantial evidence of memory difficulties in
patients with temporal lobe epilepsy, including deficits of encoding, storage and
retrieval of new information (Bortz, 2003; Leritz et al, 2006). These findings are
unsurprising, given the associated underlying neuroanatomy involved in these
seizures, including the hippocampus and surrounding medial temporal lobe
structures. Both human and animal studies have demonstrated that damage to the
hippocampus particularly impairs memory performance (Squire, 1992). Early
diagnosis and treatment is important as successful control of temporal lobe epilepsy
can reduce or prevent further damage.
Ponds and Hendriks (2006) indicate that lateralisation of the epileptogenic focus is a
crucial risk factor in determining both the severity and nature of memory
dysfunction. They indicate that patients with a unilateral left temporal lobe epileptic
focus are at a significantly increased risk of experiencing memory difficulties,
compared with patients with right temporal lobe epilepsy. However, Moore and
Baker (2002) highlight the results of studies of people with well-lateralised temporal
lobe seizure focus and those who have undergone surgical resection of the temporal
lobes (Delaney et al, 1980; Ellis et al, 1991; Jones-Gottman, 1987). Such studies
consistently support the generally held view in neuropsychology of lateralised
material specific memory deficits. This indicates that damage to left temporal lobe
leads to difficulties remembering verbally presented information (Helmstaedter et al,
1997) but right temporal lobe damage adversely affects memory for non verbal
(usually visuospatial) information (Baxendale et al, 1998). Moore and Baker (2002)
go on to say that these findings have not always been replicable. Patients who have
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experienced bilateral temporal lobe damage may become amnesic and be unable to
form new memories.
1.6 TREATMENT APPROACHES
1.6.1 Anti Epileptic Drugs (AEDs)
The majority of people who develop epilepsy (70-80%) will become seizure free
with AED therapy (Sander, 1993). However, seizures in approximately one third of
patients are more resistant to AEDs and require higher doses or polytherapy (more
than one type of AED). A number of studies report that patients taking a number of
different AEDs have significantly poorer memory performance (Elixhauser et al,
1999; Giovagnoli et al, 1997; Lammers et al, 1995).
The study of the neuropsychological effects of AEDs is complex because the
potential adverse and beneficial effects may compensate for each other. For
example, AEDs may impair memory, but may also bring benefit to memory through
seizure suppression. The current literature can only give an estimate of the side
effects of AEDs, due to methodological errors in design and an obvious lack of
consistency in assessment procedure (Cochrane et al, 2006).
Each drug has a unique pharmacodynamic and tolerability profile (Sander, 2005).
Slowing of mental or motor speed and attention deficits are documented affects of
several frequently used AEDs including carbamazepine, phenbarbital and phenytonin
(Kwan & Brodie, 2001). AEDs may adversely impact memory functions primarily
because of their detrimental effects on attention and vigilance (Helmstaedter, 2001).
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Despite the fact that many patients on long-term AED therapy report cognitive side
effects studies to confirm this have been contradictory and confounded by the effects
of chronic epilepsy (Cochrane et al, 1998; Vermeulen & Aldenkamp, 1995).
The National Institute of Clinical Excellence (2004) has based its standards for
epilepsy prescribing upon the available trial evidence together with calculations of
cost effectiveness. It concludes that carbamazepine should be the first choice for
focal/partial epilepsy and sodium valproate should be the first choice for generalised
epilepsy. However, the evidence base is surprisingly small, with few studies
comparing these drugs against newer AEDs.
The study of Standard and New Antiepileptic Drugs (SANAD) was a multi-centred
randomised control trial of longer-term clinical outcomes and cost effectiveness of
standard and new antiepileptic drugs. It involved 2,400 patients with all types of
epilepsy seen over several years (randomisation took place between 1999 sand 2004
with follow up until 2005). It was sponsored by NHS Research & Development
Health Technology Assessment Programme to determine whether these new drugs
are to be preferred in the everyday management of people with epilepsy to the
previously available standard treatments. Within this study the possible
neuropsychological affects of standard versus new antiepileptic drug treatment in
newly diagnosed patients has been explored. This was the largest study of its kind
involving many key names from the world of epilepsy research (Marson et al, 2007).
In general, results indicate that newer antiepileptic drugs appear to display minor or
no cognitive side effects.
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1.6.2 Epilepsy surgery
Surgical treatment is increasingly being used to help patients with intractable
epilepsy. This involves surgical resection of epileptogenic brain tissue of patients
with intractable seizures of focal origin. A number of different surgical procedures
are now available, including partial removal of the amygdala and hippocampus,
removal of a significant amount of the temporal lobe, partial separation of the two
hemispheres of the brain and removal of a significant amount of one hemisphere of
the brain. Approximately 80% of individuals with complex-partial seizure disorder,
especially those of temporal origin, either become seizure-free or enjoy a significant
reduction in seizure frequency (Andelman et al, 2004; Engel et al, 1997).
Neuropsychological assessment to delineate the epileptogenic lesion plays a key role
in insuring and evaluating the success of such procedures.
1.6.3 Cognitive Rehabilitation
This aspect of treatment focuses on the management of observed cognitive
dysfunction in epilepsy rather than on seizure reduction and control. Wilson (1997)
defines cognitive rehabilitation as "any intervention strategy or technique which
intends to enable clients or patients, and their families to live with, manage, by pass,
reduce or come to terms with cognitive deficits precipitated by injury to the brain"
(pp.117). In recent years, there has been increased interest in this area. However,
there is a lack of large-scale controlled studies examining the efficacy of the various
rehabilitation techniques and most of the evidence for this approach comes from
traumatic brain injury literature (Shulman & Barr, 2002). Its application and
exploration in the field of epilepsy remains largely neglected with a few exceptions
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(Aldenkamp & Vermeulen, 1991; Gupta & Naorem, 2003; Hendriks, 2001). Overall
the literature exploring cognition and epilepsy has been criticised for focusing too
much on its characterisation and description rather than treatment (Hermann &
Seidenberg, 2007).
1.7 QUALITY OF LIFE
Quality of life is a broad concept that encompasses a person's feelings of satisfaction
with various interacting areas of their daily functioning. Generally, it is accepted that
quality of life needs to address (at a minimum) satisfaction with physical, cognitive,
emotional, social and economic functioning (WHO, 1980; Hornquist, 1982: Spitzer,
1987; Fallowfield, 1990). Health care professionals and patients with epilepsy often
tend to underestimate the impact that quality of life can have on a person's well
being.
Health related quality of life refers to the way in which patients function and their
perception of well being in physical, mental and social domains of life. It
emphasises the patients' experience of health and illness and looks beyond traditional
medical assessment (Au et al, 2002). Evaluation of the impact of treatment for
epilepsy on health related quality of life is essential because functioning and
wellbeing are the outcomes that are most important to patients (Cramer, 1999;
Devinsky et al, 1995). It has long been recognised that health-related quality of life
has a major impact on successful epilepsy treatment, but research in this area remains
scarce.
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Kendrick (1997) suggests 3 key factors that may influence the quality of life of
individuals with epilepsy. These are summarised in table 3:
Factor Specific Items




Family dynamics (over protection)
Employment difficulties
Legal instructions (driving)
Psychological Cognitive Deficits (memory, concentration)
Intellectual decline
Psychiatric (depression, anxiety, behavioural
disturbance)
Table 3: Contributory factors to impaired Quality of Life in People with
Epilepsy (Kendrick, 1997)
The occurrence of recurring, unpredictable seizures is undoubtedly a major factor
affecting the life of a person with epilepsy. Seizure frequency and type and fear of
seizures have been revealed as significant predictors of well being and quality of life
in people with epilepsy (Boylan et al, 2004; Johnson et al, 2004; Sillanpaa et al,
2004). Several studies have found a significant association between quality of life
improvement and seizure reduction following temporal lobe surgery (Engel, 1997;
McLachlan et al 1997; Spencer & Spencer, 1985). Adults with well-controlled
epilepsy have been shown to have a similar quality of life compared to people with
other chronic illnesses (angina pectoris, rheumatoid arthritis, asthma and chronic
obstructive pulmonary disease) (Stavem et al, 2000). However, even patients with
well-controlled seizures report that their condition affects their lives in many ways
(Schachter et al, 1993). A diagnosis of epilepsy can bring with it many problems
over and above experiencing recurrent seizures. These include stigmatisation, social
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isolation, psychological problems and difficulties with education and employment
(Buck et al, 1999; Dijibuti & Shakarishvili, 2003; Herodes et al, 2001; Levin et al,
1988). Research exploring the influence of these factors continues to grow.
A number of studies indicate that anxiety and depression are significant predictors of
quality of life in epilepsy (Beyenburg et al, 2005; Boylan et al, 2004; Johnson et al,
2004). Au et al (2002) showed that psychosocial variables did make a significantly
independent contribution to the prediction of quality of life of patients with epilepsy
and also highlighted the importance of the influence of the subjective sense of
mastery of the condition on quality of life.
A recent Mexican study (Alanis-Guevara et al, 2005) exploring the factors
influencing quality of life indicated that socio-economic factors, sleep disturbance
and seizure control were more strongly associated with a lower quality of life than
other factors. In this study no association was found with seizure type, aetiology,
and duration of disease. Associations of depression symptoms, age and polytherapy
with lower quality of life disappeared after a multiple regression was carried out.
1.7.1 Memory & Quality of Life
Patients with resistant epilepsy, the combined effects of the underlying lesion,
uncontrolled seizures and the continuous use of antiepileptic drug treatment usually
result in impaired neuropsychological functioning that can seriously compromise
aspects of quality of life (Moore & Baker, 2002). Some studies suggest that
cognitive dysfunction may influence quality of life in epilepsy as much as clinical
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variables such as seizure activity, AEDs, and surgery. However, only two studies
have looked more specifically at the relationship between memory and quality of life
(Giovagnoli & Avanzini, 2000; Perrine et al, 1995). Giovagnoli and Avanzini (2000)
attempted to clarify the effect of memory performance on quality of life in-patients
with left or right temporal lobe epilepsy. Their main findings were that quality of
life was significantly related to both mood and self reported memory in patients with
temporal lobe epilepsy. This provided some support for the hypothesis that memory
plays a role in determining quality of life in epilepsy. However, the study has a
number of methodological limitations. Firstly, it is an Italian study and therefore its
findings may not reflect of temporal lobe epilepsy patients in the UK. Secondly,
several of the neuropsychological tests and the mood evaluation assessments used
have been demonstrated to have lower reliability and validity compared with others
used with this patient group. Finally there are also issues arising from multiple
testing. The second study investigated the effect of overall impact of cognitive
functioning on quality of life in epilepsy patients (Perrine et al, 1995). They
demonstrated a close relationship between quality of life and memory abilities in
epilepsy but mood and epilepsy related aspects also appeared to be strong predictors
of quality of life. In this study, the type of epilepsy syndrome was unspecified and
therefore participants potentially had partial and/or generalised seizures originating
from different brain areas (other than the temporal lobes). This makes firm
conclusions and generalisation to specific groups of epilepsy patient difficult. In
addition, executive functioning was somewhat neglected. These results suggested
that although seizure control and treatment of depression are vital for enhancing
quality of life, memory rehabilitation by specific training might also be effective in
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improving daily life in these patients. Conversely, another study found that well-
controlled epilepsy patients with late age onset epilepsy of relatively long duration
do not report lower health related quality of life. However, when self-reported
neuropsychological functioning was explored, difficulties were reported (Engleberts
et al, 2002).
There has been limited research exploring the possible link between cognition, and
more specifically executive functioning, and quality of life, although a relationship
has been indicated by several authors (Engleberts et al, 2002; Perrine et al, 1995;
Ringe, 2000; Trimble et al, 1994). A recent paper by Sherman et al (2006) supports
a possible link between the two in children with epilepsy. In this study significant
executive dysfunction contributed to a twofold increase in the likelihood of poor
health related quality of life. Research exploring the impact of various AEDs also
lend support to the likelhood of a relationship (Cramer & Van Hammee, 2003;
Meador et al, 2001).
1.7.2 Locus of Control, Memory & Quality of Life
Research in other areas, for example in the older adult population, indicates that there
is a relationship between locus of control and memory (Verhaeghen et al, 2000;
Soederberg et al, 2000). The data indicates that individuals with memory dysfunction
are more likely to have an external locus of control. However, there has been a
dearth of research in this area in relation to epilepsy. This is surprising given
epilepsy's unpredictable nature and the reported frequency of memory problems. A
number of studies (for example, Baker & Jacoby, 2002; Preau et al, 2005) suggest
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that higher internal locus of control is positively related to health related quality of
life in epilepsy and other chronic illnesses such as HIV.
The literature indicates that there is a relationship between locus of control and
memory functioning but is vague regarding whether memory affects locus of control
or whether locus of control affects memory. Memory functioning may influence the
type of locus of control an individual develops, which may subsequently impact on
their quality of life. Equally, it might be that locus of control influences memory
performance and consequently quality of life.
In order to achieve "true treatment success" we need to understand how individuals
perceive their disorder and, where possible, address those factors that adversely
affect their quality of life (social, vocational and psychological function). This
extends beyond seizure control to freedom from the fear associated with seizures and
their consequences, confidence in treatment and improvements in health related
quality of life (Sander, 2005).
In summary, further research exploring both the individual and combined influence
of memory functioning and locus of control on quality of life in epilepsy is required.
The results of this study may have important implications for the assessment of
epilepsy patients with memory dysfunction and the implementation of cognitive
rehabilitation programs.
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1.8 PRESENT STUDY: AIMS & HYPOTHESES
• The principal objective of this research is to explore memory functioning and
quality of life in individuals with temporal lobe epilepsy.
• Executive functioning in patients with epilepsy of temporal lobe origin will
be investigated.
• In addition, the impact of locus of control on memory functioning and quality
of life in individuals with temporal lobe epilepsy will be explored.
The following hypotheses were generated:
Hypothesis 1:
In individuals with temporal lobe epilepsy, memory functioning will be
positively correlated with quality of life.
Hypothesis 2:
Executive functioning will be positively correlated with quality of life in
individuals with temporal lobe epilepsy.
Hypothesis 3:
Memory functioning will be positively correlated with the 'internal' locus of
control subscale in individuals with temporal lobe epilepsy.
Hypothesis 4:
Memory functioning will be negatively correlated with the external locus of
control subscales ('chance', doctors and 'other people').
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Hypothesis 5:
The external locus of control subscales ('chance', 'doctors' and 'other







The Local Research and Ethics Committee and the Research and Development
Committee granted approval for data collection to begin (Appendix 1 & 2).
Following this, patients diagnosed by neurology as having simple or complex partial
seizures of definite or probable temporal lobe origin were identified as potential
participants. The local epilepsy nurse identified the majority of these participants
and where possible gauged their interest before providing the chief investigator with
contact details. A small number of individuals were also identified from the
neuropsychology department's database. A number of patients did not opt in
however, no reasons for this were provided.
The clinical neuropsychology service covers a large geographical area encompassing
Grampian, Shetland and Orkney. Patients with a range neurological disorders
(including epilepsy) are seen by the service. The epilepsy nurse fulfils a unique and
important role in the delivery of services to people with epilepsy and their carers.
In Grampian, 3,619 people (less than one percent) are recorded as having epilepsy
(out of the total population of approximately 437,812). Discussions with the
epilepsy nurse indicated that the participants approached were fairly representative of
the temporal lobe epilepsy population. However, it is important to acknowledge that
patients on the epilepsy nurse's caseload are often newly diagnosed or referred due to
significant problems arising from their epilepsy.
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2.1.1 Inclusion criteria
Patients aged between 18 and 65 years who were diagnosed with epilepsy likely to
be of temporal lobe origin were asked if they were willing to take part in the study.
The cause of the temporal lobe epilepsy varied from participant to participant. All
those approached had experienced at least two recurrent seizures over a 6 month
period at some time during the past 5 years.
2.1.2 Exclusion criteria
Individuals deemed incapable under the Adults with Incapacity (Scotland) Act 2000
were excluded from the research. This included individuals with learning disabilities
and/or those who were globally impaired as a result of head injury or stroke.
Individuals with ongoing alcohol or substance abuse, as set out in the ICD-10
(1990), and individuals with severe complicating psychiatric factors, for example
psychosis, were also excluded. In addition, individuals with special communication
needs or difficulties understanding verbal or written English were excluded.
2.2 PROCEDURE
All potential patients were sent a letter of invitation, a patient information sheet and a
consent form (Appendices 3, 4 & 5). A stamped addressed envelope was included
with the pack for return of the consent form. All participants were asked to undergo
the same assessment procedure.
The completed consent form was placed in the participant's medical file and two
copies were made (one for the patient and one for the chief investigator). Once the
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consent forms were returned participants were sent a letter inviting them to attend the
neuropsychological assessment (Appendix 6). This included details of when and
where the appointment was to be held. Participants were advised to bring glasses for
reading if required. Where possible the chief investigator and the epilepsy nurse co¬
ordinated their appointments to reduce inconvenience to participants. Arranging
appointments within normal working hours was sometimes difficult due to childcare
issues and participants' understandable reluctance to take time off work. To
overcome these difficulties the chief investigator agreed that affected individuals
could be seen out with normal working hours.
The neuropsychological assessment was undertaken at the neuropsychology
outpatient clinic. Some participants attended this appointment on their own and
others were accompanied by carers and/or significant others. It was emphasised to
those accompanying the individual that they should not, at anytime, assist the
examinee during the assessment.
Prior to each appointment, the chief investigator explored the patient's medical file
for information pertinent to the study. The details were recorded on a pre-prepared
form (Appendix 7) and included information regarding gender, handedness, social
support, medication (mono or polytherapy), age of onset, and seizure activity
(frequency and duration). The information collated was checked with the patient at
the beginning of the appointment. Following this, each participant was asked to
complete a series of neuropsychological assessments. These explored both their
memory and executive functioning. Participants were then asked to complete 3
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questionnaires: the Quality of Life in Epilepsy - 31 item questionnaire (Appendix 8),
the Multidimensional Health Locus of Control Scale (Appendix 9) and the Hospital
Anxiety and Depression Scale. The assessment took approximately 45-60 minutes to
complete.
2.3 MEASURES USED
Table 2 summarises the measures used:
Area Assessed Assessment Used Source
Memory:
Verbal Auditory Memory Logical Memory Subtest Wechsler, 1997





Colour Trail Making Test D'Elia & Satz, 1994
Response Suppression
Rule detection & following
Set Shifting Ability

















Quality of Life Quality of Life in Epilepsy
(Version 1.0)
Perrine, 1993
Table 4: Summary of Assessments
Standard "off-the-shelf' neuropsychological batteries (for example, the Halstead-
Reitan Neuropsychological battery) are sensitive to the detection of central nervous
dysfunction in a general sense, but lack specificity (Martin et al, 2006). As a result, a
flexible battery using number of different subtests and assessments was administered
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as opposed to full batteries (Sweet et al, 2006). Working in this way had the
additional benefit of reducing the time and effort each participant had to give to the
study. A description of each assessment and information regarding reliability and
validity is provided below.
2.3.1 Memory Assessment
In this within subject study, two subtests from this Wechsler Memory Scale - Third
Edition (WMS-III) were used, namely the visual reproduction and logical memory
subtests. The majority of studies exploring cognitive functioning in epilepsy use
some or all of these subtests and a number of authors recommend their use in
assessing patients with epilepsy (Martin et al, 2006).
The WMS-III was developed from its predecessor, the WMS-R. It is probably the
most widely used and most recognisable memory battery for adults (Dori & Chelune,
2004; Butler et al, 1991). It is an individually administered battery of learning,
memory and working memory measures and comprises of 11 subtests. Compared
with its predecessor, the WMS-III has greatly improved norms, both numerically and
in terms of age and ability range. The previous UK version had simply been adapted
from the USA test by modifying items that might be confusing or culturally
inappropriate for UK population. However, the tests were not standardised on the
UK population, nor were there any national studies conducted to check on the
appropriateness of the USA norms for this population. The extensive American
standardisation project (a stratified, nationally representative sample of 1,250 healthy
adults) would have been difficult to replicate and a feasible sample size for the UK
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project would not have been large enough to produce reliable and stable norms.
Therefore to utilise to fullest extent the large body of US data, it was decided that the
UK project would take the form of a validity and comparability study between
American norms and scores of a representative sample of the UK population. This
was one of, if not the largest, national cognitive data collection exercise ever
undertaken with adults in the UK (332 participants made up the final sample). Its
overall achievement was to provide sufficient information to allow well-informed
use of the USA norms in the UK (Wechsler, 1998).
2.3.1 (a) Logical Memory
Logical Memory is the most frequently administered subtest from the Wechsler
Memory Scale (Sullivan, 2005). It is a test of paragraph or prose passage recall
(immediate and delayed) in which two short stories are presented orally. The first
story was presented once and the second story twice. The examinee was then asked
to retell the stories from memory immediately after presentation. Following a delay
of approximately 25-35 minutes the participant was again asked to recall the stories.
Their recall was scored according to criteria laid out in WMS-III manual. The raw
scores were then converted into standard scores for immediate and delayed recall.
The Logical Memory subtest is an ecologically valid measure resembling the
everyday memory demands found in conversation, the media and written material.
2.3.1 (b) Visual Reproduction
The Visual Reproduction subtest indicates how well an individual can recall visually
presented information following both a short and long delay. A series of five designs
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was shown, one at a time, for approximately 10 seconds. After each design was
presented, the examinee was asked to draw the design from memory. After
approximately 25-35 minutes, the examinee was asked to draw the learned designs
from memory in any order. Their efforts were scored according to standardised
criteria and their raw scores combined and converted into standard scores (one for
immediate and one for delayed).
2.3.2 Assessment of Executive Functioning
The following measures explore different aspects of patients executive functioning
for example, mental flexibility, inhibition, rule following, processing speed and
attention:
2.3.2 (a) Colour Trails Test (CTT) ( D'Elia et al, 1996)
This test has been adapted from the Trail Making Test (TMT) (Reitan & Wolfson,
1993). It is said to measure a wide range of abilities (complex visual scanning,
motor speed and agility, mental sequencing, sustained visual attention, processing
speed and frontal functioning (set shifting and cognitive flexibility). In this study,
processing speed and frontal functioning in particular were being investigated.
The CTT was developed in 1990 in response to the World Health Organisation multi
centre for HIV infection requesting a similar test to the TMT but with a broader
application in cross cultural settings free as possible from the influence of language.
This means it can also be used with individuals who have specific language
difficulties such as dyslexia. There is an increasing amount of evidence supporting
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use the CTT over the TMT (Chan & Lee, 2000; Moses, 2004). Moderate correlations
with the TMT parts A and B (r = .41 and .50) have been demonstrated in adults (Maj
et al, 1993).
The CTT uses colour rather than English alphabet letters. Each test has circles
printed with vivid pink or yellow backgrounds that are also perceptible to colour
blind individuals. There are 2 parts to the test. In part 1 of the test, the respondent
was asked to connect circles numbered 1 through to 25 in sequence. This gave an
indication of the individuals processing speed and visual attention and tracking
abilities. In part 2, the respondent was asked to join numbered circles in sequence,
but to alternate between pink and yellow colours. This provided valuable
information about participants' cognitive flexibility and set shifting abilities.
2.3.2 (c) Controlled Word Association Test (COWAT)
(Benton & Hamsher, 1976)
The COWAT measures, mental flexibility, multiple response generation, and
maintenance of complex task set, intrusion set, perseveration, language ability and
use of vulgar or socially inappropriate words. It is widely used by neuropsychologists
(Mitrushina et al, 1999) and its reliability and validity are well documented (Lezak,
2004; Spreen & Strauss, 1998). Temporal lobe epilepsy has been associated with
deficits on tests of letter fluency (Lezak, 2004).
The COWAT consists of three word naming trials. Norms are provided for letters on
the basis of the frequency of English words beginning with these letters. In each set
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of three letters, words beginning with the first letter have a relatively high frequency,
the second letter has somewhat lower frequency, and the third letter has an even
lower frequency. Participants are given a minute to provide as many words they can
think of that begin with that letter, excluding proper nouns, numbers and the same
word with a different suffix. The score is the sum of all acceptable words produced
in the three one minute trials. This score can be adjusted for age, sex and education
(Benton et al, 1994).
The associative value of each letter of the alphabet, except X and Z, was determined
in a normative study using normal control participants (Borkowski et al, 1967).
Control participants of low ability tended to perform less well than brighter brain
damaged individuals, highlighting the necessity of taking the patient's premorbid
verbal skill level into account when evaluating mental flexibility.
2.3.2 (c) Hayling & Brixton Tests (Burgess & Shallice, 1997)
This assessment has been revealed to be sensitive to the types of problems seen in
patients with dysexecutive problems (Burgess & Shallice, 1997). It has been shown
to have moderate ecological validity (Odhuba & Broek, 2005).
The Hayling Sentence Completion Test
The Hayling Sentence Completion Test provides a measure of basic task initiation
speed as well as performance on a response suppression task. Performance on such
tests has been repeatedly associated with dysexecutive symptoms in everyday
situations (Burgess, 1997). The Hayling test shows moderate bivariate correlations
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with other measures of excutive function, including the Six Elements Test (Clark et
al, 2000; Marczewski et al, 2001).
Both sections of the Hayling consist of 15 sentences, each missing the last word.
These have been adapted from those presented in Bloom and Fischler (1980). In the
first section, the participant was asked to complete sentences with the pre-potent
response for example, responding as quickly as possible with the word 'ship' when
presented with the sentence 'The captain went down with the sinking '. The
time taken for them to respond to each item was recorded and converted into a
standard score.
In the second section, the subject was asked to suppress the pre-potent response and
complete the sentence with a completely unrelated word as quickly as possible for
example, giving the response 'door' to complete the sentence 'London is a very busy
....'. Participants who perform poorly on this task produce answers which either
clearly complete the sentences, or that are closely related to semantic aspects of them
or take a long time to suppress responses. Higher scoring participants will usually
develop strategies to help them deal with the response suppression demands of the
task (for example, naming items they can see in the surrounding environment), and
nearly all their responses will be unconnected to the sentence.
The number and type of errors and the time taken to respond was recorded.
Comparison of the error score and response times in section two may enable a
judgement to be made about the style of failure. In other words, impulsive
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individuals were either impulsive and responded quickly with errors or were slow in
responding but accurate. This task gives three scores, an error score (from section 2)
and two measures of response speed (sections one and two). An overall scaled score
ranging from 1 (impaired) to 10 (very superior) was used for analysis.
Brixton Spatial Awareness Test
The Brixton Spatial Awareness Task is a rule detection and rule following task.
Impairments on such tests are possibly the most commonly demonstrated
impairments in people with dysexecutive problems (Anderson et al, 1991; Bondi et
al, 1993; Miller, 1992). It is conceptually similar to the Wisconsin Card Sorting Test
(WCST) (Heaton, 1981). Indeed, one of its advantages is that it manages to
overcome some of the difficulties encountered when using the WCST for example it
has been suggested that it is less time consuming and less stressful (Crawford &
Henry, 2005). Individuals are asked to uncover the rules regarding the placement of
a blue circle among a grid of blank circles. The rule changes when a particular
pattern is established. The total errors were recorded and an overall scaled score,
ranging from 1 (impaired) to 10 (very superior) was calculated.
The Hayling and Brixton assessments are quickly and easily administered, reducing
assessment time and the potential for participants to become fatigued or distressed.
They have moderate reliability and moderate specificity and sensitivity (Crawford &
Henry, 2005). A recent study indicates that these tests have reasonable ecological
validity and that they contribute to understanding the impact of executive functioning
on everyday activity (Odhuba & Broek, 2005).
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2.4 OTHER AREAS ASSESSED
2.4.1 Hospital Anxiety and Depression Scale (HADS)
(Zigmond and Snaith, 1983)
The HADS is a screening tool originally devised for detecting depression and anxiety
in general medical settings. When conducting a neuropsychological assessment with
epilepsy patients it is important to include a measure of mood (Perrine et al, 1995).
The HADS has been used in several studies of psychological outcome in epilepsy
(Jacoby et al, 1996; O'Donoghue et al, 1999) and widely in studies of several other
medical conditions, including neurological diseases and cancer. HADS scores have
been shown to correlate strongly with other depression rating scales and with
psychiatric assessments. Its use has been validated in several studies across various
medical and psychiatric conditions (Mensah et al, 2006). This is a useful instrument
for use with epilepsy patients as it has fewer items that could potentially be affected
directly by epilepsy rather than being true markers of anxiety or depression for
example, dizziness and headaches. Good internal consistency for the anxiety and
depression subscales has been reported (0.88 and 0.82) for a community epilepsy
sample (Jacoby et al, 1996).
This scale is comprised of 14 items, from which two scores are calculated for anxiety
and depression. A four-point Likert scoring system is used for each item. Scores
range between 0 and 21 for each subscale. Scores of 8 to 10 are obtained by mildly
disturbed clients (borderline or 'doubtful cases') and scores of 11 to 21 are likely to
indicate definite anxiety and depression. The score considers only negative aspects
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of mood and therefore a score of less than 8 cannot be equated with psychological
well being.
2.4.2 Quality of life in epilepsy - 31 Item (QOLIE-31 )(Version 1.0)
(Cramer et al, 2003; Perrine, 1993)
Several scales have been developed and validated to evaluate quality of life in
epilepsy patients. Epilepsy specific scales combine sections of general scales with
issues relevant to individuals with epilepsy and have been demonstrated to be more
sensitive to change in this population than general scales (Birbeck et al, 2000). The
most widely used epilepsy-specific quality of life outcome measures are the Quality
of Life in Epilepsy (QOLIE) questionnaires (Privitera & Ficker, 2004). The
QOLIE-31 is a survey of health related quality of life for adults (18 years or older)
with epilepsy comprising 31 questions about health and daily activities. The QOLIE-
31 is a shorter (more efficient) version of the QOLIE-89 and was derived by
selecting subscales considered to be most important for epilepsy patients while
excluding some general topics (Privitera & Ficker, 2004). It contains seven multi-
item scales that tap the following health concepts: emotional wellbeing, social
functioning, energy/fatigue, cognitive functioning, seizure worry, medication effects
and overall quality of life. One question exploring participants' "health concept" is
also included in the inventory but does not contribute to the overall score.
The QOLIE-31 has been shown to have good reliability and validity (Vickrey et al,
1993). Item selection for the QOLIE-31 was based on analysis of data collection
from a cohort of 304 adult men and women having different types of seizures of mild
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to moderate severity. These patients were enrolled from 25 sites across the United
States. All subjects completed a 98-item QOLEE test battery. This was administered
to the majority of participants again 3 weeks later. A brief neuropsychological
battery, neurological exam, a proxy's assessment of the participants' quality of life
and information about seizure occurrence were also obtained (Devinsky et al, 1995;
Perrine, 1993). Following data analysis, three measures of quality of life were
developed, differing in their number of items: the QOLEE-89, the QOLIE-31 and the
QOLIE-IO. Internal consistency reliabilities for the multi-item scales ranged from
0.77 to 0.85, exceeding the 0.70 standard for group-level comparisons (Nunally,
1978).
The instrument was scored in accordance with the test manual, with composite scores
derived from the subscale scores. A score ranging from 1 to 100 was obtained for
each subscale, with higher numbers indicating a higher quality of life.
2.4.3 Multidimensional health locus of control questionnaire (MHLC)
(Wallston et al, 1994)
This is widely used to characterise a person's beliefs about control over health
outcomes. There are three MHLC scales in all. In this study form C was selected
(Wallston et al, 1994). It is designed to be 'condition specific' and can be used in
place of forms A and B when studying people with an existing health/medical
condition (in this case epilepsy). In common with forms A and B it has 'internal'
and 'chance' subscales (of six items each). However, instead of the single six item
'powerful others' subscale, it has two, independent three item subscales: 'doctors'
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and 'other people'. For each item, there is a six point agree-disagree response scale.
The MHLC's internal reliability has been reported to be in the range of 0.83 to 0.85
(Au et al, 2002). Construct validity was established by a positive correlation
between the internal health locus of control and health status, as well as a negative
correlation between chance health locus of control and health status (Winefield,
1982).
Four independent scores were calculated, with high scores indicating a strong belief
in the subscale locus of control measured.
2.5 ETHICAL CONSIDERATIONS
The local research and ethics board passed this study in February 2007 (Appendix 1).
Some of the key ethical issues considered in this research are outlined below:
2.5.1 Confidentiality
All data will be stored and retained by the Chief Investigator for five years in
accordance with research guidelines. Data will be stored according to NHS policies
regarding confidentiality in a locked filing cabinet on NHS premises. All data were
made anonymous at the initial recruitment stage, with each consenting individuals
assigned a number used to identify them thereafter. Information will be stored on the
computer in this form. The list of identification numbers and participant consent
forms will be kept in a locked cabinet in the department of clinical neuropsychology.
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2.5.2 Distress during Assessment
It was not anticipated that this investigation would cause any distress to participants.
However, it was made clear that in the unlikely event that participants reacted in an
unexpected way and/or became upset the assessment would be stopped. In addition,
the participants had the chief investigator's contact details and it was made clear that
they could contact her if they had any concerns regarding their participation.
2.5.3. Capacity Issues
It was foreseen that there might have been issues in relation to an individual's
capacity to consent to participate in this research. It was therefore agreed that if
there was any doubt regarding an individual's ability to consent they would be
excluded.
2.5.4 Other Ethical Issues
It was possible that assessment might reveal severe general or more specific
cognitive and/or psychological dysfunction (clinical significant anxiety or
depression) not previously revealed. If this occurred it was agreed that the chief
investigator would discuss sharing this information with the epilepsy nurse. Suicidal
ideation might also have been discovered. If this occurred it was agreed that the on-
call psychiatrist would be contacted as soon as possible.
2.6 DATA ANALYSIS
Only 2 studies explored related comparisons in this area and one of these did not
report effect size and/or means and standard deviations from which effect sizes could
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be calculated (Giovagnoli and Avanzini, 2000). However, the paper by Perrine et al
(1995) explored the relationship of neuropsychological functioning to quality of life
in epilepsy and reported a significant correlation with memory (r=.42). This finding
combined with a power analysis table from the following website give an
approximate estimate of the required N for this study:
http://www.rowett.ac.uk/~gwh/corr.html. In this case a minimum of approximately
35 participants was required for required significance levels (alpha = 0.50 and power
= 0.80).
The Kolmogorov-smirnov test was conducted on the data. This showed that the data
was normally distributed and therefore justified the use of parametric tests. A
parametric test is one, which is based on certain assumptions about the properties of
the population from which samples are taken. All statistical analyses were run using
SPSS Version for Windows. Pearson correlations were used to investigate
relationships between variables.
The number of correlations to be conducted increased the risk of type 1 error i.e. the
risk of stating that a result is significant when it is not. This suggests that if one
conducted an experiment using random data, 1 in 20 times (on average) a result at







Of the 44 patients who were approached, 22 opted into the study giving an overall
response rate of 50%. All those who opted in were included in the study and there
was no missing data. The age of participants ranged from 22 to 60 years of age
(mean = 41.3 years; sd = 9.8 years) and the age range of those who did not respond
ranged from 17 to 64 years (mean = 34.4 years; sd = 12.1 years). Table 5
summarises the gender and age groups of those who opted in and those who did not.
Gender Age

































Table 5: Gender & Age Groups of Participants & Individuals who
Did Not Respond
Table 6 shows the deprivation category which the participants and those who did not
respond were likely to belong to. This was calculated using the Carstairs and Morris
index of social deprivation. This index allows one to calculate levels social
deprivation according to postcode sectors and 2001 census data. The deprivation
score is divided into 7 categories ranging from very low (1) to very high social
deprivation (7).
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Carstairs & Morris Deprivation Category




























Table 6: Carstairs & Morris Index of Deprivation Score
All of the participants were right-handed. Eighteen (81.8%) reported that they were
'satisfied' or 'very satisfied' with the support they received from their family and
friends. However, several participants (including 5 participants who stated they
were 'satisfied or very satisfied') commented that people often "misunderstood" their
epilepsy and one participant mentioned their "continuous battle against old fashioned
views". One individual (4.5%) commented on how their employers and family were
sometimes "overprotective" and another confessed that they had kept their diagnosis
from the majority of their friends and family and from their work colleagues.
3.1.2 Seizure Activity (Cause, Onset, Frequency)
The majority of participants (16 or 71.7%) had temporal lobe epilepsy of 'cause
unknown'. Five of the participants (22.7%) developed temporal lobe epilepsy as a
result of congenital malformation and one individual (4.5%) had developed it
following a brain haemorrhage. Nine (40.9%) had received their diagnosis over ten
years ago, two (9.1%) between 5-10 years ago and ten (45.5%) had received their
diagnosis sometime over the past five years. Only one individual (4.5%) had been
diagnosed in the past year. Sixteen participants (72.7%) had experienced at least
one seizure in the past 6 months and five (22.7%) of these had experienced seizures
sometime within the week preceding the assessment. When discussing seizure
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activity, a number of participants mentioned both their fear of having seizures and
the potential repercussions. They were particularly concerned about the impact
seizure activity might have on their independence and employment prospects.
3.1.3 Employment Issues
Thirteen (59%) of the participants were employed full-time, four (18.2%) part-time
and five (22.7%) were unemployed. They were involved in a range of occupations
including engineering, teaching, employment within the sales and service sector. All
those who were unemployed commented that they had been forced to stop working
due to their epilepsy and four (18.2%) of those in full time employment had either
changed careers or altered their jobs to meet the challenges posed by this condition.
Five (22.7%) were self-employed.
3.1.4 Anti Epileptic Drugs (AEDs)
Thirteen participants (63.6%) were on a monotherapy regime and eight (36.4%) were
on a polytherapy course of AEDs. The main AEDs prescribed to the participants
included Epilim, Tegretol, Keppra, Lamotrigine, and Carbmazepine.
3.1.5 Psychological Functioning
The Hospital Anxiety and Depression Scale (HADS) was administered to determine
whether participants may have had significant anxiety and/or depression. The
overall mean for anxiety (mean = 8.1; sd = 3.8) was higher than the mean for
depression (mean = 4.5; sd = 3.3). Figure 2 shows participants' scores (with cut off
for clinical significance). Eight (36.7%) individuals scored above the cut off for
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clinically significant anxiety (merits further psychiatric assessment). Six participants
(27.3%) scored within the mildly depressed range (considered 'doubtful cases') but
no one presented with above the cut off for clinically significant depression.
= HADS Anxietv
= HADS Depression
Figure 2: Participants' HADS Scores
3.2 EXPLORATION OF HYPOTHESES
3.2.1 Hypothesis 1;
In individuals with temporal lobe epilepsy, memory functioning will be
positively correlated with quality of life.
Overall, there was considerable variation in the sample's performance on verbal and
visual memory (immediate and delayed). Five (22.7%) participants performed
within the moderate to severely impaired range on both immediate verbal and visual
memory. One (4.5%) participant displayed severe difficulties with immediate verbal
memory but had average immediate verbal memory. After a delay, six participants
(27.3%) displayed moderate to severe difficulties in both tasks. One participant
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(4.5%) presented with significant difficulties in verbal memory and one (4.5%) had
difficulties with visual memory only.
Figure 3 shows the overall quality of life score for each participant and demonstrates
variability across the sample. An overall quality of score ranging from 1 to 100 was
obtained with higher numbers indicating a higher quality of life. The mean average
score for the general population has been calculated at 62.87 (sd = 16.31). The
overall quality of life mean for all those assessed was 56.2 (sd = 20.4).
100
1 3 5 7 9 11 13 15 17 19 21
Participants
Figure 3: Participants' Quality of Life Scores
Pearson correlations did not reveal a significant positive relationship between
immediate verbal memory and quality of life (r = 0.41, n = 22, p =.030, one-tailed)
but did reveal a significant relationship between immediate visual memory and
quality of life (r = 0.60, n = 22, pc.OOl, one-tailed).
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A positive correlation between delayed verbal memory and quality of life was
revealed (r = 0.45, n = 22, p = .018, one-tailed) but this was not significant at pc.01.
A positive correlation was revealed between performance on delayed visual memory
and quality of life (r = 0.61, n = 22, p<.001, one-tailed). The correlation with
delayed visual memory is displayed in Figure 4:
Quality of Life
Figure 4: Delayed Visual Memory & Quality of Life
3.2.2 Hypothesis 2:
Executive Functioning will be positively correlated with quality of
life in individuals with temporal lobe epilepsy.
Different aspects of executive functioning were explored using five executive
functioning assessments. Overall, participants demonstrated relative strengths and
weaknesses in executive functioning. Participants performed less well on the
sustained attention (Colour Trails part 1) and the Hayling and Brixton Tests. Six
(27.3%) scored below average on the Colour Trails Test 1. Nine (40.9%) displayed
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significant difficulties on the Hayling Sentence Completion Task and six (27.3%)
displayed significant difficulties on the Brixton Sentence Completion Task.
Participants did not present with significant difficulties with the Controlled Word
Association Test (COWAT) or Colour Trails 2 and Pearson correlation revealed that
these three tasks were not significantly associated with overall quality of life. The
results of the Pearson correlations between the executive functioning tasks and
quality of life are summarised in Table 7. Controlling for memory did not impact
greatly on the correlations revealed.
N Quality of Life
Trails 1 Pearson Correlation 22 r = 0.54
(1-tailed) p<.005
Trails 2 Pearson Correlation 22 r = 0.30
(1-tailed) p = .089 NS
COWAT Pearson Correlation 22 r = 0.28
(1-tailed) p = .102 NS
Hayling Pearson Correlation 22 r = 0.58
(1-tailed) p = .002
Brixton Pearson Correlation 22 r =0.50
(1-tailed) p =.009
Table 7: Correlations between Executive Functioning Tasks & Quality of Life
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Pearson correlations showed a positive correlations between quality of life and
performance on the Colour Trails part 1 (r = 0.54, n = 22, p<.005, one-tailed), the
Hayling Sentence Completion Test, (r = 0.58, n = 22, p = .002, one-tailed) and the
Brixton Test (r = 0.50, n = 22, p = .009, one-tailed).
3.2.3 Hypothesis 3:
Memory functioning will be positively correlated with the 'internal' locus
of control subscale in individuals with temporal lobe epilepsy.
The 'internal' subscale from the Multidimensional Health Locus of Control Scale did
not show a significant correlation with either the immediate verbal memory score (r
= -0.34, n = 22, p = .062, one-tailed) or the delayed verbal memory score (r = -0.23,
n = 22, p = .152, one-tailed). No correlation was revealed between either the
immediate (r = -0.43, n = 22, p = .024, one-tailed) or delayed visual memory (r = -
0.16, n = 22, p = .239, one-tailed) and the 'internal' locus of control subscale.
3.2.5 Hypothesis 4;
Memory functioning will be negatively correlated with the external locus
of control subscales ('chance', doctors and' other people') in individuals
with temporal lobe epilepsy.
Pearson correlations revealed significant negative relationships between immediate
verbal memory and two of the external locus of control scales ('chance' and 'other
people'). No relationship was found between immediate visual memory and
'chance' or 'doctors' but a significant negative correlation was revealed between
immediate visual memory and 'other people' (r = - 0.53 n = 22, p = .005, one-tailed).








22 r = -0.53
p = .005
r = -.0.31
p = .078 NS
Doctors Pearson Correlation
(1-tailed)
22 r = -0.38
p= .039 NS
r = -0.03
p = .450 NS
Other People Pearson Correlation
(1-tailed)




Table 8: Correlations between Immediate Memory (Visual & Verbal) &
External Locus of Control Subscales
Significant negative relationships were revealed between delayed verbal memory and
the 'other people' subscale (r -0.67, n = 22, p<.001, one-tailed). No significant
relationships were revealed between delayed verbal memory and the 'chance' and
'doctors' subscales. Delayed visual memory only correlated with the 'other people'
subscale (r = -0.53, n = 22, p = .005, one-tailed). The results of these correlations are








22 r = -0.44
p = .022 NS
r = -.0.18
p = .209 NS
Doctors Pearson Correlation
(1-tailed)
22 r = -0.47
p = .013 NS
r = -0.03
p = .450 NS
Other People Pearson Correlation
(1-tailed)




Table 9: Correlations between Delayed Memory (Visual & Verbal) & External
Locus of Control Subscales
3.2.6 Hypothesis 5:
The external locus of control subscales ('chance', 'doctors' and 'other
people') will be negatively correlated with quality of life in temporal lobe
epilepsy.
Pearson correlations did not reveal any significant relationships between the external
locus of control subscales and quality of life in temporal lobe epilepsy. These results
are summarised in Table 10.
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N Quality of Life
Chance Pearson Correlation
(1-tailed)
22 r = -0.14




p = .419 NS
Other People Pearson Correlation
(1-tailed)
22 r = 0.34
p = .064 NS
Table 10: Correlations between Multidimensional Health Locus of
Control External Subscales & Quality of Life
3.3 OUTLIERS
During statistical analysis there were a number of outliers identified. Each of these
outliers was explored, but as there were no reasons to suppose that they were not
valid data, they were included in analyses. The individuals identified were revealed





This study aimed to investigate whether individuals with temporal lobe epilepsy and
difficulties with their memory functioning experience lower quality of life. The
impact of executive functioning and locus of control on memory and quality of life in
temporal lobe epilepsy was also explored. It was suggested that these two variables
exerted a significant influence on the main research question posed. Participants
underwent a battery of neuropsychological assessments and completed
questionnaires assessing locus of control, quality of life and psychological
functioning.
The main findings of this study are presented and discussed in relation to each of the
hypotheses put forward in the introduction. The theoretical and clinical implications
of these results are considered. Finally, the methodology of this study is evaluated
and suggestions for further research proposed.
4.1 GENERAL ISSUES
Initially participants were asked for background information regarding their epilepsy.
The key issues arising from this are discussed below.
There were over twice as many females than males in the group that did not respond
to the invitation to participate. The majority of all these individuals were within the
18-39 years age range. In addition, over half of this group had a social deprivation
score of four or more compared with those who opted in, of whom the majority
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scored within the less deprived categories (categories 1-3). As a result of the latter
point, individuals who did not respond were more likely to have had more financial
limitations compared with the majority of the participants. These limitations could
potentially have meant that time off from employment, additional childcare costs and
access to transport made participation difficult.
The majority of participants' epilepsy was of 'cause unknown'. This figure is in
keeping with previous studies which indicate that 60-70% of epilepsies are of
unknown aetiology (Sander, 2003). All except one of the participants had
experienced seizures in the past six months and a small number had experienced
seizures in the week preceding the assessment. Almost half the sample had been
given their diagnosis more than 10 years ago and a number had been given their
diagnosis in childhood. This was interesting given the evidence which suggested that
the duration epilepsy is positively correlated with the degree of neurocognitive
dysfunction exhibited (Strauss et al, 1995). Almost half of the participants were on a
polytherapy regime of antiepileptic medication. This was unsurprising given that the
epilepsy nurse was the main source of research participants and often sees people
with uncontrolled epilepsy.
Fear of seizures and concerns about the consequences and functional limitations of
the seizures themselves were raised (for example, the social and financial
implications of being unable to drive). Comments made about the
misunderstandings that can occur and the social stigma people feel were unsurprising
given the history of this condition and the reports of many working in the field
67
(Shafer, 2002). The reactions given and the support and encouragement provided by
significant others has been highlighted as key in helping individuals to cope and
adjust to epilepsy and this seemed to be the case for many of the participants in this
study. An accurate understanding of epilepsy is vital in facilitating this adjustment,
as is containment of anxiety (Usiskin, 2005). Conversely in some situations, families
and/or significant others can become too involved and overprotective and there is a
risk that this may lead to illness behaviour and increased dependency (Usisikin,
2005). Providing education and support could potentially help dispel the myths and
misconceptions surrounding the epilepsy, reduce the emotional impact of seizures,
improve both individuals and their family' adjustment to epilepsy and ultimately
improve quality of life (Gupta & Naorem, 2003). Education of wider society might
also be an issue to consider when attempting to overcome the stigma often attached
to this condition. This might include speaking to a variety of different groups in
society such as politicians and school children.
The majority of those in the sample were employed. However, exploration of
participants' comments revealed that many faced daily challenges at work as a result
of their epilepsy. The challenges identified included fear of seizures, social stigma
and cognitive difficulties. A significant number were self-employed and several
commented that they had been denied their preferred occupation or had been
compelled to adapt their employment as a result of their epilepsy. Work has many
functions aside from financial reward. It provides a way of structuring time, and
more importantly, contributes to a person's identity and feelings of self-worth
(Thompson & O'Toole, 2005). For many people with epilepsy, employment
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presents as a major quality of life issue and unemployment can potentially contribute
to the increased psychopathology often observed in epilepsy (Baker, 2005).
None of the participants scored highly on the depression measure. This may reflect a
selection bias, as significantly depressed individuals may not have opted into this
research due to lack of motivation and lethargy, common symptoms of depression.
Higher levels of anxiety were revealed in the sample. This is in keeping with the
literature which highlights the prevalence of anxiety in epilepsy (Beyenburg et al,
2005; Vazquez & Devinsky, 2003).
When considering these results, the impact of anxiety had to be taken into account.
High levels of anxiety have been shown to adversely affect performance on many
different kinds of mental ability tests (Lezak et al, 2004). A number of participants
were shown to have clinically significant anxiety and it is possible that this impacted
on their performance, especially on the memory tasks. Unlike executive functioning
tasks, participants are more likely to notice when memory is being assessed due to
the nature of the test material used and this may affect their performance.
4.2 HYPOTHESES
4.2.1 Hypothesis 1:
In individuals with temporal lobe epilepsy memory functioning will be
positively correlated with quality of life.
A positive correlation was revealed between both verbal and visual memory
(immediate and delayed) and quality of life, although only visual memory of was
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significant at the p<.01 level. These finding lend support to the hypothesis and
indicate that individuals with temporal lobe epilepsy and average or above average
memory will tend to report higher quality of life than individuals with temporal lobe
epilepsy who experience memory problems. However, it is difficult to know if this
relationship is more pronounced in epilepsy, or whether memory and quality of life
would be equally correlated with other clinical groups (for example, those with
traumatic brain injury or multiple sclerosis) or with non-memory impaired groups.
There is a dearth of literature exploring quality of life and memory in epilepsy
generally and more specifically in temporal lobe epilepsy. Current research indicates
that memory and cognitive abilities are predictive of quality of life (Giovagnoli et al,
1999; Perrine et al, 1995; Trimble et al, 1994). Research with other patient groups
for example, those who have sustained a brain injury, older people and schizophrenic
patients, lends support to these findings (Hawley, 2006; McDermid et al, 2002).
Work conducted by LoGiudice et al (1999) demonstrates that the quality of life of
carers is also is also influenced by memory problems. The findings of the present
study are consistent with the available literature in this area and highlight the
potentially significant impact that memory functioning can have on quality of life.
Difficulties in recalling information may influence many different aspects of life
including activities of daily living (personal care, housework), social interactions and
employment.
These results go some way to support the view that conducting neuropsychological
assessment with individuals who have temporal lobe epilepsy is important.
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Neuropsychological assessment highlights potential problems, provides useful
information regarding an individual's cognitive strengths and weaknesses and
provides a valuable baseline against which future assessments can be measured. This
information can be used to improve the individual's psychological well being and
quality of life. The role clinical neuropsychology can play in both the assessment
and treatment of cognitive dysfunction in epilepsy process is being increasingly
recognised in health service documents for example, in the NICE Guidelines on
Epilepsy. Ideally all newly diagnosed patients with epilepsy should undergo a brief
neuropsychological screen prior to starting treatment (Baxendale, 2005). In addition,
due to the valuable information it provides about the individual's cognitive profile,
neuropsychological assessment is seen as a prerequisite for planning and
implementing individually tailored cognitive rehabilitation programmes which have
been shown to improve an individual's functioning in 'real life' contexts (Gupta &
Naorem, 2003).
The results of this study coupled with the above research indicate that methods to
ameliorate memory problems might improve the quality of life of individuals with
temporal lobe epilepsy. However, there is a lack of empirical research to guide the
treatment of memory dysfunction in epilepsy. Cognitive dysfunction is usually
managed indirectly with aggressive seizure control, selection of antiepileptic drugs
shown to have fewer cognitive side effects, and treatment of co-morbid depression
and/or anxiety (Shulman & Barr, 2002).
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In recent years, cognitive rehabilitation has been the focus of much attention in
neuropsychology. However, most of the research in this area takes the form of case
studies or non-controlled small studies and randomised control trials are scarce
(Ponds & Hendriks, 2006). In addition, very few studies have investigated cognitive
rehabilitation for memory difficulties in epilepsy specifically. Particular factors have
been identified as important when considering memory difficulties in epilepsy. The
severity and frequency of seizures, seizure site, antiepileptic medication, surgery,
mood and age on onset have all been shown to influence memory functioning
(Thomson, 1997). The chronic nature of epilepsy increases the likelihood that
memory problems will appear and increase over time and this may reduce the
individual's quality of life (Ponds & Hendriks, 2006).
A number of suggestions have been put forward regarding the most effective way to
design memory rehabilitation programs for individuals with epilepsy (Aldenkamp &
Vermeulen, 1991). The key points made in relation to this include: goal planning for
the individual, relating strategies to everyday contexts; psycho education;
considering the impact of personality and emotional reactions and exploring the
individual's perception of their memory problems (Ponds & Hendriks, 2006). Gupta
and Naorem (2003) stress the need to establish more effective remedial programmes
for the deficits in cognitive functioning associated with epilepsy and are of the
opinion that these would be "of substantial benefit" to this client group. They
present a case study that describes a six-session cognitive rehabilitation programme
combined with regular home intervention sessions. The strategies taught involved
helping their patient to organise information more effectively to aid their memory for
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example, chunking and categorising information and using imagery. The individual
demonstrated good use of the taught strategies and an improved emotional and
behavioural state following this intervention.
4.2.2 Hypothesis 2:
Executive Functioning will be positively correlated with quality of
life in individuals with temporal lobe epilepsy.
Moderate positive relationships were revealed between three of the executive
functioning tasks and quality of life. These tasks included the Colour Trails part 1
and the Hayling and Brixton tests. No significant relationships were revealed
between quality of life and the Controlled Word Association Test or the Colour
Trails part 2. These findings provide partial support for the above hypothesis. In this
study the executive functioning measures were still significantly correlated with
quality of life when memory was controlled for and vice versa.
The correlation discovered between quality of life and the Colour Trails part 1
(which assesses processing speed and sustained attention) is interesting, especially
given that no correlation was revealed between the more difficult Colour Trails 2
(divided attention and set-shifting task) and quality of life. Issues with sustained
attention in epilepsy have been raised and some go so far as to suggest that it is more
significant in predicting academic failure than memory or socio-economic factors
(Sanchez-Carpintero, 2003; Van Rijckevorsel, 2006). Reduced processing speed is
also often found in patients with epilepsy (Engleberts et al 2002) and several papers
suggest that this is a frequent side effect of antiepileptic medication (Dodrill 1988;
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Meador, 2001). There is some evidence to indicate that temporal lobe epilepsy
patients with reduced white matter volumes exhibit impaired information processing
speed performance on the Wisconsin Card Sorting Test compared with both temporal
lobe epilepsy patients with normal white matter volume and healthy controls (Dow et
al, 2004).
Consideration should be given to the potential influence of sustained attention on
memory processing. If an individual does not attend to information it will not be
encoded sufficiently for later recall. Given the results revealed in relation to
hypothesis one, such memory deficits are likely to have a 'knock on' effect on
quality of life.
Almost half of the individuals' assessed demonstrated difficulties on the Hayling
Sentence Completion Task suggesting that they had difficulties with basic task
initiation speed and response suppression and just over 25% demonstrated significant
difficulties on the Brixton Spatial Awareness Task. Both of these tasks correlated
with quality of life. These results support the increasing evidence which indicates
that executive dysfunction is present in temporal lobe epilepsy and is particularly
noticeable in higher multilevel executive tasks (Bougakov, 2005; McDonald et al,
2005).
Performance on executive functioning tasks has been repeatedly associated with
dysexecutive symptoms in everyday situations. Executive dysfunction may manifest
itself as 'odd' or unusual behaviour which can be challenging for those who are part
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of an individual's support network and can impact on the individual's quality of life.
Such behaviour may be misinterpreted due to a lack of understanding or awareness
and could potentially lead to social isolation and stress. Executive dysfunction may
also present more subtly and only become apparent in high level executive tasks,
which are more often encountered in work settings. Such difficulties may have
significant implications for individuals whose work makes such cognitive demands
(Ringe, 2000).
Several papers point to the existence of a relationship between cognition, executive
functioning and quality of life in epilepsy (Engleberts et al, 2002; Perrine et al, 1995;
Ringe, 2000; Trimble, 1994). A more recent paper demonstrates that executive
dysfunction is a significant predictor of quality of life in children with epilepsy
(Sherman, 2006). Evidence from other areas, for example research conducted with
patients who have severe and enduring mental illness, also reveal that executive
functioning is predictive of quality of life issues such as family contact and financial
support (Fujii et al, 2004).
No correlation was found between the set shifting, mental flexibility and quality of
life. The evidence for the presence of these difficulties in epilepsy is limited and
inconsistent. It may be that set shifting and mental flexibility are less of an issue
than the other areas of executive functioning in relation to everyday functioning and
quality of life. Alternatively, set shifting and mental flexibility may not have been
directly related to self-perceived functional daily activities or well being as assessed
by the quality of life measure. This does not necessarily mean they can be ignored.
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In addition, the Hayling and Brixton tests have been shown to have reasonable
ecological validity (Crawford & Henry, 2005) whereas the ecological validity of the
Controlled Word Association test has been questioned (White, 2005).
These results suggest that efforts to improve quality of life in epilepsy might include
interventions for executive dysfunction possibly similar to the cognitive
rehabilitation programmes used to help patients with memory problems. However
the question of whether executive dysfunction can be effectively treated remains
unanswered. Conclusions drawn from a review of the literature are "cautiously
positive" but many issues remain (Evans, 2005). Executive functions are poorly
defined and theoretical irregularities makes evaluation of rehabilitation studies
difficult and this has probably limited the number of studies undertaken. Some of the
most persuasive work addressing rehabilitation of executive functions has been done
with individuals who have a diagnosis of schizophrenia (Penades et al, 2006;
Silverstein et al, 2004). Overall, substantially more high quality research is needed
to determine whether specific aspects of executive functioning can be improved
through tailored interventions in individuals with temporal lobe epilepsy. As is the
case with cognitive rehabilitation for memory dysfunction, comprehensive
assessment of executive functioning will be required when planning any
interventions (Crawford & Henry, 2005).
Generally existing research supports the notion that cognitive abilities (memory and
executive functioning), as perceived by the patient and assessed by formal testing,
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impact significantly on everyday functioning and quality of life (Perrine et al, 1995).
These findings reinforce this view. However, executive dysfunction in temporal lobe
epilepsy is often overshadowed by the more commonly reported memory difficulties.
Those working with individuals with temporal lobe epilepsy must be mindful of its
potential influence not just in the lab but also in 'real world'.
4.2.3 Hypothesis 3:
Memory functioning will be positvely correlated with the 'internal' locus
of control subscale in individuals with temporal lobe epilepsy.
No relationship was revealed between verbal memory (immediate and delayed) and
the 'internal' locus of control subscale or between visual memory (immediate and
delayed) and the 'internal' locus of control subscale. Overall, these findings do not
support the hypothesis.
The author proposed that difficulties in memory functioning resulting from temporal
lobe epilepsy might cause individuals to become increasingly more reliant on others
for assistance and consequently less independent. It was suggested that this might
cause individuals to develop the belief that they had little personal control over their
epilepsy. This assumption was based on information from the literature which
suggested a potential relationship between internal locus of control and memory
dysfunction in epilepsy and other chronic illnesses (Baker & Jacoby, 2002; Preue et
al, 2005). However, in this study, memory difficulties did not lead people with
temporal lobe epilepsy to perceive they had less personal control over their epilepsy.
It may be that other factors are more important in influencing feelings of internal
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control, for example there is substantial evidence pointing to the role of depression in
decreasing internal locus of control. The finding that participants did not appear to
have significant levels of depression would support this possibility.
4.2,4 Hypothesis 4:
Memory functioning will be negatively correlated with the external locus
of control subscales ('chance', doctors and 'other people') in individuals
with temporal lobe epilepsy.
Analysis of data revealed significant negative relationships between verbal memory
(immediate and delayed) and the two of the three external subscales ('other people'
and 'chance'). Visual memory was shown to correlate significantly with the 'other
people' subscale only. These findings provide only partial support for the above
hypothesis, at least in relation to verbal memory. They indicate that memory
dysfunction in temporal lobe epilepsy potentially increases the possibility of
individuals believing that chance and significant others play an important role in how
their epilepsy behaves.
Those with significant memory dysfunction are more likely to have intractable
epilepsy with frequent seizure activity. As a result of this, individuals will be in
more regular contact with doctors and other health professionals as efforts continue
to bring their epilepsy under control. These people are also more likely to require
higher levels of support from their family and friends to help them adapt and cope
with the challenges posed by their epilepsy. Good social support may help
contribute to the self-management of the epilepsy, including the use of cognitive
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strategies, and may help to moderate the effects of social stigmatisation (Dilorio et al,
1992). The importance of good social support in predicting of quality of life in this
condition has been highlighted (Au et al, 2002).
These results support the view that the involvement of significant others in the
treatment and management of epilepsy is important. They also support the
usefulness of empowering patients themselves to take action to minimise the impact
epilepsy can have on everyday life. The cognitive rehabilitation programmes and
strategies referred to previously may offer some solutions and assist in helping
people feel more in control where memory functioning is an issue. Unfortunately,
there is little high quality research exploring interventions that might help people
with epilepsy self-manage and ameliorate some of the negative effects of epilepsy.
In addition, the majority of this work to date tends to describe the issues but fails to
come up with solutions (Baker & Moore, 2002).
A strong belief in the influence of chance may decrease a person's own feelings of
personal control over their epilepsy. Both the ever-present threat and uncertainty
about when the next attack will occur have been shown to leave individuals feeling
isolated and misunderstood. It is likely that memory dysfunction will exacerbate this
uncertainty and unpredictability and potentially increase the likelihood of chance
being seen as significant. Difficulty recalling information can result in increased
anxiety and frustration and reduced self confidence. This has potential repercussions




The external locus of control subscales ('chance', 'doctors' and 'other
people') will be negatively correlated with quality of life in temporal lobe
epilepsy.
No significant correlations were revealed between the external locus of control
subscales and quality of life. These findings do not support the above hypothesis.
It was inferred that individuals with higher scores on these subscales would report
lower quality of life. This inference was based on literature which indicated that
higher scores on external locus of control measures are associated with depression,
and negative consequences of epilepsy such as perceived severity and social stigma
(De Villis et al, 1986). More specifically the influence of self-efficacy in the
prediction of health related quality of life in epilepsy has been found by several
authors (Amir et al, 1999; Au et al, 2002). Participants from the Au et al (2002)
study who believed their health condition was significantly a matter of chance
reported poorer quality of life.
There are a number of possible reasons why no relationship was revealed between
these two variables. It may be that many individuals, particularly those who have
had epilepsy for many years, adopt a more stoical view of their epilepsy and accept
whatever challenges it presents them with. They are focused on living their lives
despite these hurdles. In addition, it may be that doctors and other people actually
provide some protection against reported lower quality of life. This would relate to
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the literature which stresses the value of support from significant others in
maintaining stable psychological well being and quality of life.
43 CONCLUSIONS
This research provided support for the hypotheses 1 and 2. Overall memory and
executive functioning correlated with both quality of life in individuals with temporal
lobe epilepsy. Hypothesis 4 received some partial support but there was no evidence
to support hypotheses 3 and 5. A number of correlations were revealed between
memory and the 'chance' and 'other people' subscales. However, memory
functioning did not correlate with the 'internal' locus of control subscale and the
external locus of control scales did not correlate with quality of life in temporal lobe
epilepsy.
The key findings and their potential implications as follows:
• Cognitive dysfunction (memory and executive dysfunction) in individuals
with temporal epilepsy can significantly disrupt quality of life.
• Neuropsychological assessment could potentially provide useful information
regarding the individual's cognitive strengths and weaknesses. This can be
used to monitor changes in cognition and to inform treatment.
• Improved quality of life should be viewed as an important outcome of
successful treatment.
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The results of this study would indicate that intervention for cognitive
dysfunction is important (due its impact on quality of life). Cognitive
rehabilitation for memory and executive dysfunction is suggested as one
such treatment but considerably more research is required to investigate its
efficacy.
Clinical neuropsychology has an important role to play in the assessment and
treatment of cognitive dysfunction. To meet this need the provision and
organisation of clinical neuropsychological services needs to be investigated.
The role of clinical neuropsychology and health psychology in educating both
individuals and their families and wider society about epilepsy is also
proposed to be important.
Locus of control is perhaps not one of most important factors to consider in
relation to quality of life, although is cannot be discarded completely. It
remains something to be mindful of, especially in relation mental health
issues and treatment.
When assessing and working with this client group it is important to be
mindful of the influence of anxiety in epilepsy and to consider the potential




One of the difficulties in drawing conclusions about the results of this study is the
reduced power due to the smaller than anticipated numbers. Power calculations
indicated that approximately 35 patients would have been required. Despite the chief
investigator's best efforts, it was not possible to recruit this number of participants.
The epilepsy nurse was the main source of patients for the study. With hindsight it
might have been useful to have involved the consultant neurologists in the patient
recruitment process as well. This might have improved the likelihood of reaching
power and potentially provided access to a wider range of patients. Regarding the
latter point, participants who were seeing the epilepsy nurse tended to have various
problems arising from having more intractable temporal lobe epilepsy or from having
a recent diagnosis. However, the advantage of using the epilepsy nurse was that she
had more frequent contact with patients and therefore was able to comment with
more confidence on their suitability for the study in relation to the
inclusion/exclusion criteria.
During the selection of neuropsychological assessments to be used in the study it was
difficult to find any that were specifically for use or had been validated on epilepsy
populations. In addition, there was little consistency in the tests used when
investigating cognition in epilepsy. This finding relates to the review by Cochrane et
al (1998) which highlights inconsistency in the use of neuropsychological
assessments in epilepsy. They recommended epilepsy specific neuropsychological
instruments and increased uniformity in selection of tests. Increased consistency in
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the assessment tools used would help both researchers and clinical practitioners to
reach conclusions and make recommendations with more confidence and certainty.
Following ethical approval, a number of possible alternatives to particular
assessments used came to light. Future work in this area might make use of these. A
new screening tool for identifying major depression and anxiety in patients with
epilepsy has been recently published (Cole, 2006). The Neurological Disorders
Depression Inventory for Epilepsy (NODEE) might have been a useful alternative to
the Hospital Anxiety and Depression Scale as it has been standardised specifically
for use in this population. A new measure has been very recently developed from the
Quality of Life in Epilepsy- 31 Item questionnaire used in this study. The QOLIE-
31-P includes additional questions regarding how much distress patients feel about
problems and worries related to epilepsy. However, the disadvantage of this measure
is that it includes additional questions, which means a longer assessment period for
each patient. In relation to the QOLIE-31, a recently published paper by Tracy et al
(2007) reveals that its scores strongly reflect psychological state, primarily depressed
mood, and that factors such as seizure control exert a more limited effect on the
QOLIE. This suggests that health related quality of life measures where mood does
not play such a dominant role are required.
In relation to the subtests used from the Wechsler Memory Scale - Third Edition
(WMS-III), the chief investigator wondered if it had been necessary to separate the
immediate and delayed scores. It might have been more straightforward to combine
them to have two overall scores for verbal and visual memory. In addition,
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information from Bell et al (2004) suggests that separate immediate and delayed
WMS-III indices are not necessary in this population. Utilising other memory
assessments, such as the California Verbal Test - Second Edition, might also have
been interesting as it would have provided more detailed information about different
aspects of verbal learning and memory. However, due to the number of assessments
being administered it was decided that this would take too long to administer and
could potentially cause unnecessary stress to participants.
It would have been interesting to have had a control group in this study comprised of
individuals from taken from a non-epileptic clinical population or from group who
did not have memory or executive dysfunction. This would have clarified whether
the relationship found between memory function and quality of life is more
pronounced in epilepsy, or whether memory and quality of life would be equally
correlated in other groups.
4.5 FUTURE RESEARCH
During the course of this investigation, a number of areas for possible future research
came to light.
There is a lack of research exploring cognitive rehabilitation for both memory and
dysexecutive problems in epilepsy. Such work could have significant clinical
relevance and implications for the quality of life of patients with temporal lobe
epilepsy.
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In this study only the perspective of the individuals with epilepsy themselves were
sought. Future studies might like to involve and explore the views and thoughts of
the individuals' families and/or significant others. Research indicates that significant
others may feel grief for the patient, fears for safety, doubts about their own ability to
cope and/or resentment due to disruption in their own lives (Usiskin, 2005). In
addition, there is research that suggests that cognitive function may impact on the
quality of life of carers as well.
Impairment of long-term recall may worsen everyday functioning of patients with
epilepsy even if standard short term or delayed recall tests do not show significant
abnormalities (Mameniskiene et al, 2006). Individuals with epilepsy frequently
complain of memory problems yet perform within normal range on standard
neuropsychological memory assessments. It has been suggested that this is due to
impairment of very long-term memory consolidation processes which may reflect the
disruptive effects of seizures on long-term consolidation of new information
(Schulman & Barr, 2002; Blake et al, 2000). This long-term impairment may have
missed this in this study as the tests used required retention of new information at a
standard 25-30 minute delay. Potentially this long-term impairment, which remains
outside of routine cognitive assessment, could be more important to everyday living
than immediate and delayed recall (Mameniskiene, 2006).
A number of studies suggest that area of lateralisation is an important area to
consider. There is some evidence indicating that individuals with unilateral left
epileptic focus have significantly increased risk of memory dysfunction compared
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with patients with right temporal lobe epilepsy (McDonald et al, 2005). This also
relates to the debate regarding material specific deficits. Future work in this area
would possible help to clarify this issue.
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Full title of study: Do temporal lobe epilepsy patients with memory
problems experience higher external locus of control and
lower quality of life than those who do not?
REC reference number: 07/S0802/10
Thank you for your letter of 26 February 2007 and email of 23 March 2007, responding to the
Committee's request for further information on the above research and submitting revised
documentation.
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the
above research on the basis described in the application form, protocol and supporting
documentation as revised.
Ethical review of research sites
The Committee has not yet been notified of the outcome of any site-specific assessment
(SSA) for the research site(s) taking part in this study. The favourable opinion does not
therefore apply to any site at present. We will write to you again as soon as one Research
Ethics Committee has notified the outcome of a SSA. In the meantime no study procedures
should be initiated at sites requiring SSA.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out. You
are advised to study the conditions carefully, in particular:
/S0802/10 Page 2
Condition 1: Annual Progress Report
Under the Central Office of Research Ethics Committees (COREC) regulations NHS
Research Ethics Committees are required to monitor research with a favourable opinion.
This is to take the form of an annual progress report which should be submitted to the
Grampian Research Ethics Committee 12 months after the date on which the favourable
opinion was given. Annual reports should be submitted thereafter until the end of the study.
Points to note:
• The first annual progress report should give the commencement date for the study. This
is normally assumed to be the date on which any of the procedures in the protocol are
initiated. Should the study not commence within 12 months of approval a written
explanation must be provided in the 1st annual progress report.
• Progress reports should be in the format prescribed on the COREC website
(www.corec.orq.uk/applicants/apply/proqress.htmT
• Progress reports must be signed by the Principal Investigator/Chief Investigator.
• Failure to submit a progress report could lead to a suspension of the favourable ethical
opinion for the study.
• Please note the Annual Progress Report is a short 3 page form which is extremely easy
to complete.
Condition 2: Notification of Study Completion/Termination
Under the Central Office of Research Ethics Committees (COREC) regulations researchers
are required to notify the Ethics Committee from which they obtained approval of the
conclusion or early termination of a project and to submit a Completion/Termination of Study
Report. Researchers should follow the instructions on the COREC website
(www.corec.org.uk/applicants/apply/endofproject.htm).
Points to note:
• For most studies the end of a project will be the date of the last visit of the last participant
or the completion of any follow-up monitoring and data collection described in the
protocol.
• Final analysis of the data and report writing is normally considered to occur after formal
declaration of the end of the project.
• A Final Report should be sent to the GREC within 12 months of the end of the project.
• The summary of the final report may be enclosed with the end of study declaration, or
sent to the REC subsequently.
• There is no standard format for final reports. As a minimum we should receive details of
the end date and information on whether the project achieved its objectives, the main
findings and arrangements for publication or dissemination of research, including any
feedback to participants.
07/S0802/10 Page 3
• Please note the Completion/Termination of Study Report need only be a summary
document and should, therefore, be easy to prepare.
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document Version Date
Application 5.3 18 January 2007
Investigator CV 20 June 2006
Protocol 31 August 2006
Covering Letter 26 February 2007
Letter from Sponsor 1 December 2006
Compensation Arrangements 28 July 2006
Letter of invitation to participant 2 26 February 2007
Participant Information Sheet 2 26 February 2007
Participant Consent Form 2 26 February 2007
Response to Request for Further Information 26 February 2007
Letter to Dr Gerrie 1
CV: Fiona Summers 20 July 2006
CV: Paul Morris
R&D approval
The study should not commence at any NHS site until the local Principal Investigator has
obtained final approval from the R&D office for the relevant NHS care organisation.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for
Research Ethics Committees (July 2001) and complies fully with the Standard Operating
Procedures for Research Ethics Committees in the UK.
07/S0802/10 Please quote this number on all correspondence
With the Committee's best wishes for the success of this project
Yours sincerely
Dr Sheila A Simpson
Chair
Enclosures: Standard approval conditions
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Project title: Do temporal lobe epilepsy patients with memory problems experience higher
external locus of control and lower quality of life than those who do not?
Thank you very much for sending all relevant documentation. I am pleased to confirm that
the project is now registered with the NHS Grampian Research & Development Office.
The project has R&D Management Approval to proceed locally.
Please note that if there are any other researchers taking part in the project that are not
named on the original Ethics application, please advise the Ethics Committee in writing
and copy the letter to us so that we may amend our records and assess any additional
costs.





Letter of Invitation to Participate


















I have enclosed information about research being conducted with patients who appear
to have epilepsy of temporal lobe origin. This study will explore memory and the
control people believe they have over their health. It will also investigate the impact
of these factors on quality of life. This research is being carried out by Roisin Jack,
trainee clinical psychologist as part of her Doctorate in Clinical Psychology.
I thought you might be interested. An information sheet giving details of the study
and a consent form are enclosed. If you wish to participate, please return the consent











Study exploring the individual and combined influence ofmemory problems and
beliefs about control over health on quality of life in temporal lobe epilepsy
You are being invited to take part in a research project. Before you decide it is important for
you to understand why this research is being done and what it will involve. Please take time
to read the information provided below and talk to others about the study if you wish.
What is the purpose of the study?
There is a lack of research exploring whether there is a link between memory, the amount of
control people feel they have over their health and quality of life in temporal lobe epilepsy.
These may be important things to consider in the care of patients with epilepsy.
Why have I been chosen?
You have been chosen because you have a diagnosis of temporal lobe epilepsy. You were
identified as a possible participant by Sheena Bevan, Epilepsy Nurse and/or from the
Department of Neuropsychology. It is hoped that 35 participants will take part.
Do I have to take part?
No, it is up to you to decide whether or not to take part. If you do, you will be given this
information sheet to keep and be asked to sign a consent form. You are free to withdraw at
any time and without giving a reason.
What will happen to me if I take part?
• Data for this study will be collected between February and May 2007.
• You will be asked to attend a neuropsychological assessment lasting approximately
45 minutes at either Aberdeen Royal Infirmary orWoolmanhill Hospital.
• This neuropsychological assessment will involve answering questions and
completing a number of tasks exploring your memory and other thinking processes.
• All information will be kept strictly confidential. The procedures for handling,
processing, storage and destruction of your data are compliant with the Data
Protection Act 1998.
• Access to your medical notes will be required to check details regarding medication
and diagnosis.
• If you agree to take part, you may be contacted about taking part in future studies.
Will I receive feedback?
It is anticipated that feedback regarding the overall results of the study will be given in the
form of a letter and/or presentation during August/September 2007. Unfortunately, feedback
on individual performance will not be provided.
What if I chose not to participate or withdraw from the study?
You are free to choose not to participate or withdraw at any time and without giving a reason.
In such circumstance all identifiable material will be destroyed if you wish. A decision to
withdraw at any time, or a decision not to take part, will not affect the standard of care you
receive.
Further Information
Please take time to consider whether or not you wish to take part. Please contact me if you
would like further information:
Roisin Jack (Trainee Clinical Psychologist)




Thank you for taking time to read this form




Title of Study: Study exploring whether there is a relationship between locus
of control and quality of life and memory impairment in epilepsy
Name of Researcher. Roisin Jack
Please initial box
1. I confirm that I have read and understood the information sheet dated for
the above study. I have had the opportunity to consider the information, ask questions
and have these answered satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw at any time,
without giving any reason, without my medical care or legal rights being affected.
3. I understand that relevant sections of any of my medical notes and data collected during
the study, may be looked at by responsible individuals from the NHS Trust or Edinburgh
University, where it is relevant to my taking part in this research. I give permission for
these individuals to have access to my records.
4. I agree to take part in the above study.
5. I would like to be contacted about any follow up studies.
Name of Patient Date Signature
Name of Researcher Date Signature
Patient Identification Number for this trial:
Original Version of this document should be kept in medical notes
Upon completion Cc: Patient
Researcher Site File
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Re: Memory Functioning and Quality of Life in Temporal Lobe Epilepsy
Thank you for agreeing to participate in the above study. Your help is very much
appreciated. I would like to see you for neuropsychological assessment.
Your appointment details are as follows:
Aberdeen Royal Infirmary, Ward 40
9am on Wednesday I2th April 2007
If you wear glasses please bring these with you to the appointment. Please do not
hesitate to contact me if you have any queries regarding this study or if you are unable







Please circle the appropriate response
Space has been provided for any extra comments
1. Gender: Male Female
Handedness Right Left
2. How satisfied are you with your level of social support?
1 2 3 4 5
Very Dissatisfied Neither Satisfied Satisfied Very Satisfied
Dissatisfied nor Dissatisfied
Comments:
3. Employment Status: Employed Employed Unemployed
(full time) (part time)
Comments:
When was your first seizure?
4. When was the last time you had a seizure?
Last week Last month Last 3-6 months Last year Over a year ago
Comments:
5. How would you rate your epilepsy?
Mild Moderate Severe
6. Please tick which type of anti epileptic medication are you currently taking
(trade name is written in brackets)?
1st Line Drugs 2nd Line Drugs
Carbamazepine (Tegretol) Clobazam (Frisium)
Ethosuximide (Zarontin) Clonazepam (Rivotril)
Phenytoin (Epanutin) Gabapentin (Neurontin)








7. Do you have memory problems? Yes No
If yes, how much do these impact on your everyday life?




Quality of Life in Epilepsy (QOLIE-31) Version 1.0
QUALITY OF LIFE IN EPILEPSY
QOLIE-31 (Version 1.0)
Patient Inventory
Today's Date / /
Patient's Name
Patient's ID# Gender □ Male □ Female
Blrthdate / /
Have you completed this questionnaire prior to today's visit? □ Yes □ No
MD Name ;
INSTRUCTIONS
This survey asks about your health and daily activities. Answer every question by circling
the appropriate number (1, 2, 3...).
If you are unsure about how to answer a question, please give the best answer you can and
write a comment or explanation in the margin.
Please feel free to ask someone to assist you if you need help reading or marking
the form.
1. Overall, how would you rate your quality of life?
(Circle one number on the scale below)
© © © © © ©
10 987654321 0
Best Possible Worst Possible
Quality of Life Quality of Life
(as bad as or
worse than
being dead)
These questions are about how you FEEL and how things have been for you during
the past 4 weeks. For each question, please indicate the one answer that comes
closest to the way you have been feeling.
How much of the time during the past 4 weeks...



















2. Did you feel
full of pep?
1 2 3 4 5 6
3. Have you been
a very nervous
person?
1 2 3 4 5 6
4. Have you felt so
down in the dumps
that nothing could
cheer you up?
1 2 3 4 5 6
5. Have you felt
calm and peaceful?
1 2 3 4 5 6
6. Did you have
a lot of energy?
1 2 3 4 5 6
7. Have you felt
downhearted
and blue?
1 2 3 4 5 6
8. Did you feel
worn out?
1 2 3 4 5 6
9. Have you been
a happy person?
1 2 3 4 5 6
10. Did you feel
tired?
1 2 3 4 5 6
11. Have you worried
about having
another seizure?
1 2 3 4 5 6







1 2 3 4 5 6
13. Has your health
limited your social
activities (such as 1 2 3 4 5 6
visiting with friends
or close relatives)?
How has the QUALITY OF YOUR LIFE been during the past 4 weeks (that is, how
have things been going for you)?*
(Circle one number)







15. In the past 4 weeks, have
you had any trouble with
your memory?
1 2 3 4
This question asks about how often in the past 4 weeks you have had trouble
remembering or how often these memory problems have interfered with your normal
work or living.
All Most A good
of the of the bit of





of the of the
time time
16. Trouble remembering
things people tell you
1 2 3 4 5 6
The following questions are about CONCENTRATION problems you may have.
Circle one number for how often in the past month you had trouble concentrating
or how often these problems interfered with your normal work or living.
All Most A good














1 2 3 4 5 6
The following questions are about problems you may have with certain ACTIVITIES.
Circle one number for how much during the past 4 weeks your epilepsy or
antiepileptic medication has caused trouble with...
A great Only Not
deal A lot Somewhat a little at all
19. Leisure time
(such as hobbies, 1 2 3 4 5
going out)
20. Driving 1 2 3 4 5
The following questions relate to the way you FEEL about your seizures.










21. How fearful are
you of having a
seizure during the
next month?






















23. How worried are you
about embarrassment or
other social problems
resulting from having a
seizure during the
next month?
1 2 3 4
24. How worried are you
that medications you
are taking will be bad
for you if taken for
a long time?
1 2 3 4
For each of these PROBLEMS, circle one number for how much they bother you





25. Seizures 1 2 3 4 5
26. Memory difficulties 1 2 3 4 5
27. Work limitations 1 2 3 4 5
28. Social limitations 1 2 3 4 5
29. Physical effects of antiepileptic
medication
1 2 3 4 5
30. • Mental effects of antiepileptic
medication
1 2 3 4 5
How good or bad do you think your health is? On the scale below, the best imaginable
state of health is 100 and the worst imaginable state is 0. Please indicate how you
feel about your health by circling one number on the scale. Please consider your



















Multidimensional Health Locus ofControl Scale (MHLC)
Form C
Instructions: Each item below is a belief statement about your medical condition with which you may agree or
disagree. Beside each statement is a scale which ranges from strongly disagree (1) to strongly agree (6). For
each item we would like you to circle the number that represents the extent to which you agree or disagree
with that statement. The more you agree with a statement, the higher will be the number you circle. The more
you disagree with a statement, the lower will be the number you circle. Please make sure that you answer
EVERY ITEM and that you circle ONLY ONE number per item. This is a measure ofyour personal beliefs;
obviously, there are no right or wrong answers.
l=STRONGLY DISAGREE (SD) 4=SLIGHTLY AGREE (A)
2=MODERATELY DISAGREE (MD) 5=MODERATELY AGREE (MA)
3=SLIGHTLY DISAGREE (D) 6=STRONGLY AGREE (SA)
SD MD D A MA SA
1
Ifmy condition worsens, it is my own behavior which determines how soon I will
feel better again.
1 2 3 4 5 6
2 As to my condition, what will be will be. 1 2 3 4 5 6
3 If I see my doctor regularly, I am less likely to have problems with my condition. 1 2 3 4 5 6
4 Most things that affect my condition happen to me by chance. 1 2 3 4 5 6
5
Whenever my condition worsens, I should consult a medically trained
professional.
1 2 3 4 5 6
6 I am directly responsible for my condition getting better or worse. 1 2 3 4 5 6
7
Other people play a big role in whether my condition improves, stays the same, or
gets worse.
1 2 3 4 5 6
8 Whatever goes wrong with my condition is my own fault. 1 2 3 4 5 6
9 Luck plays a big part in determining how my condition improves. 1 2 3 4 5 6
10
In order for my condition to improve, it is up to other people to see that the right
things happen.
1 2 3 4 5 6
11
Whatever improvement occurs with my condition is largely a matter of good
fortune.
1 2 3 4 5 6
12 The main thing which affects my condition is what I myself do. 1 2 3 4 5 6
13
I deserve the credit when my condition improves and the blame when it gets
worse.
1 2 3 4 5 6
14 Following doctor's orders to the letter is the best way to keep my condition from
getting any worse.
1 2 3 4 5 6
15 If my condition worsens, it's a matter of fate. 1 2 3 4 5 6
16 If I am lucky, my condition will get better. 1 2 3 4 5 6
17
Ifmy condition takes a turn for the worse, it is because I have not been taking
proper care ofmyself.
1 2 3 4 5 6
18
The type of help I receive from other people determines how soon my condition
improves.
1 2 3 4 5 6
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